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Zusammenfassung 
 
Ceramid-Synthasen (CerS) sind hochkonservierte Transmembranproteine, die für die 
Sphingolipid-Biosynthese notwendig sind. CerSs tragen eine TLC (Tram-Lag1-CLN8)-
Domäne, die ein konserviertes Lag1p-Motiv enthält, das für die Ceramidsynthese 
erforderlich ist. Viele der CerS-Enzyme enthalten auch eine Homöodomäne. Obwohl 
Homöodomain-Proteine bekanntermaßen die Transkription über die DNA-Bindung 
regulieren, ist die Homöodomain-Funktion von CerSs nicht genau untersucht und frühere 
Studien bezweifelten sogar, dass sie als Transkriptionsfaktor fungieren könnte.  
In jüngster Zeit konnte gezeigt werden, dass das Drosophila-Homolog namens "Schlank" 
nicht nur in der Sphingolipidbiosynthese, sondern auch in der Regulation von Körperfett 
involviert ist. Die Regulierung des Körperfettanteils ist zudem unabhängig von der CerS-
Aktivität. Neben der Lokalisierung am Endoplasmatischen Retikulum, wie auch die Säuger 
CerS, ist Schlank auch an der inneren Kernmembran (INM) lokalisiert. Zwei nukleare 
Lokalisierungsstandorte (NLS1, NLS2) sind für die nukleare Lokalisierung des Proteins 
notwendig. 
Um die Homöodomänenfunktion von der katalytischen zu unterscheiden, wurden in vivo 
Homöodomänen-Fliegenmodelle generiert und analysiert. Die Mutation am NLS2-Standort 
wirkte sich stark auf die Lipolyse und Entwicklung aus und demonstrierte eine wesentliche 
Funktion der Schlank-Heimatdomäne bei der Regulierung des Körperfettstoffwechsels und 
des Wachstums.  
Diese Arbeit zeigt, dass Schlank die Promotor-Regionen von Lipasen (z.B. Lip3) über die 
Homöodomäne bindet und die Transkription direkt reguliert. Mutationen des NLS2-
Standortes führten zum Verlust der DNA-Bindung und deregulierten Genexpression. Dieser 
Mechanismus scheint im Säuger CerS2 konserviert zu sein. 
Darüber hinaus passt Schlank die Transkriptionsregulation an den Energiestatus an. Werden 
die Fliegen gehungert nimmt die nukleare Lokalisation und damit die Bindung an die DNA 
ab. Auf der anderen Seite reagiert Schlank auf sich ändernde Fettsäurespiegel (essentielle 
Moleküle in der Sphingolipidbiosynthese), erhöht die nukleare Lokalisation und reguliert 
die Genexpression.  
Diese Studie demonstriert eine Doppelfunktion von CerS Schlank als Enzym und 
Transkriptionsregulator, indem sie den Lipidspiegel misst und die Informationen auf die 
Ebene der Genexpression transformiert. Diese Funktion ist erforderlich, um die Lipid-
Homöostase zu regulieren und aufrechtzuerhalten. 
  
  
  
 
Abstract 
Ceramide synthases (CerS) are highly conserved transmembrane proteins necessary for 
sphingolipid biosynthesis. CerSs carry a TLC (Tram-Lag1-CLN8) domain, containing a 
conserved Lag1p motif required for ceramide synthesis. Many of the CerS enzymes also 
contain a homeodomain. Although homeodomain proteins are known to regulate 
transcription via DNA binding, the homeodomain function of CerSs is frequently not 
investigated and previous studies doubted that it could act as a transcription factor.  
Recently, it has been shown that the Drosophila homologous of CerS called “Schlank”, is 
not only involved in sphingolipid biosynthesis but also in the regulation of body fat. 
Moreover, the regulation of body fat is independent of CerS activity.  
Besides localizing at the endoplasmic reticulum, as each mammalian CerSs, Schlank also 
localizes at the inner nuclear membrane (INM). Two nuclear localization sites (NLS1, 
NLS2) are necessary for the nuclear localization of the protein. 
In order to distinguish the homeodomain function from the catalytic one, in vivo 
homeodomain animal models were generated and analyzed. The mutation in the NLS2 site 
severely affected lipolysis and development, demonstrating an essential function of the 
Schlank homeodomain in the regulation of body fat metabolism and growth.  
This work shows that Schlank binds the promoter regions of lipases (e.g., lip3) via the 
homeodomain and directly regulates transcription. Mutations of the NLS2 site led to loss of 
DNA binding and deregulated gene expression. This mechanism seems to be conserved in 
mammalian CerS2.  
Furthermore, Schlank adjusts transcriptional regulation according to the energy status. Upon 
starvation, nuclear localization and consequently DNA binding diminish. On the other hand, 
Schlank responds to changing fatty acid levels (essential molecules in sphingolipid 
biosynthesis), increasing nuclear localization and regulating gene expression.  
This study demonstrates a double function of CerS Schlank as an enzyme and a 
transcriptional regulator, sensing lipid levels and transducing the information to the level of 
gene expression. This function is required to adjust and maintain lipid homeostasis. 
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 1 
1 Introduction  
 
Cellular processes are mediated by the orchestrated action of numerous biomolecules that 
form complex interaction networks. The cellular interactome, protein-protein, protein–DNA, 
and protein– metabolite are extraordinarily complex interaction networks (Gavin et al., 
2010). Two-thirds of the cellular proteome operates at a membrane surface or within a 
membrane comprising thousands of different lipid species.  
Different types of eukaryotic cells differ for lipids-membrane composition. Cells need to 
sense the concentration of every single lipid, assimilate those signals and regulate the activity 
of different enzymes to fit the demands of the membranes. A small fraction of membrane 
lipids, which levels always need to be adjusted to maintain the fluidity and the subdomain 
structure of the lipid bilayers are sphingolipid (Futerman and Hannun, 2004). Besides being 
simple structural lipids, sphingolipids are known to be bioeffector molecules (Hannun and 
Obeid 2008). Bioactive sphingolipids such as Ceramide, sphingosine-1-phosphate, 
sphingosine and complex sphingolipids such as glucosylceramide, function as signaling 
molecules. They are involved in several biological processes including apoptosis, cell 
proliferation, cell migration and inflammation (Reynolds et al., 2004; Fox et al., 2006). 
Altered sphingolipid regulation, metabolism, or storage is linked to several human diseases. 
The most common and multifactorial are for instance metabolic disorders (diabetes and 
insulin resistance), cancer pathogenesis (incidence and progression) (Schiffmann et al., 
2009), and Alzheimer’s disease (Farooqui et al., 2010; van Echten- Deckert & Walter, 2011). 
Some lower incident or hereditary diseases are, for instance, Nieman-Pick disease 
(Schweitzer et al., 2009), and Gaucher disease (Fuller et al., 2010). 
 
1.1 Sphingolipid biosynthesis 
 
The chemical reactions and the enzymes involved in sphingolipid biosynthesis are well 
known, and are highly conserved during the evolution (Figure 1.1). Ceramide is the 
molecular precursor for all complex sphingolipids, and it is synthesized at the cytosolic face 
of the endoplasmatic reticulum (ER). Ceramides consist of a long-chain sphingoid base to 
which a CoA-activated fatty acid residue of different chain length is attached via an amide 
bond. In the de novo synthesis pathway, dihydrosphingosine is N-acylated to 
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dihydroceramide by Ceramide Synthase (CerS) (Kolesnick et al., 2000). Under 
physiological conditions the so formed ceramides, are readily consumed; transported to the 
Golgi with a vesicular or non-vesicular (by CERT, ceramide transfer protein) related 
mechanism and converted to complex sphingolipids. From the salvage pathway (breakdown 
of complex sphingolipids), glycosphingolipids and sphingomyelin are degraded by several 
lysosomal enzymes (glycosidase, acid- and neutral-sphingomyelinase and acid ceramidase) 
to sphingosine (that can be then reacylated to ceramide), ceramide and phosphorylcholine 
(Marchesine and Hannun, 2004; Kitatani et al., 2008). Vice versa under stress conditions, 
ceramide can accumulate leading to apoptosis (Obeid et al., 1993). All of these mechanisms 
place CerSs at the center of the sphingolipid metabolism. 
 
 
 
Figure 1.1. Schematic of sphingolipid biosynthetic and salvage pathways. SPT—serine 
palmitoyltransferase, KDSR—3-keto-dihydrosphinganine reductase, CerS—ceramide synthase (various 
isoforms in mammals), DEGS—dihydroceramide desaturase (various isoforms), C1PP—ceramide-1-
phosphate phosphatase, Acyl-CoA—fatty acyl coenzyme A, NADPH—nicotinamide adenine dinucleotide 
phosphate, reduced. Image modified from Zabielski et al., 2017. 
A 
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1.2 Ceramide Synthase functional domains 
 
CerSs are multispanning transmembrane proteins, and although the exact number of 
transmembrane domains (TM) and their topology has not been resolved experimentally, 
based on TM prediction tools the going assumption is based on an odd number (5 to 7) of 
TM (Tidhar R. et al., 2018). CerSs are a family of highly conserved enzymes, expressed in 
all eukaryotes (Voelzmann and Bauer, 2010).  
The first CerS gene was found in a study in Saccharomyces Cerevisiae. It was initially 
described as longevity assurance gene (LAG1) because its deletion promoted longevity in 
yeast (Mello et al., 1994). Subsequently, different LAG1 homologs were identified as CerS 
genes. In mammals, ceramide is synthesized by a family of six CerS (CerS1 to CerS6) that 
structurally share a distinct 200 amino acid domain, the Tram-Lag-CLN8 (TLC) domain, 
described as a lipid-sensing domain. Within the TLC domain lies, the Lag1p motif, a 
conserved stretch of 52 amino acids indispensable and responsible for the enzymatic activity 
of the protein. Two consecutive and conserved histidine (H) residues are likely to be 
involved either in the catalysis or substrate binding (Spassieva et al., 2006). Each CerS has 
a preference for a selected range of acyl-CoA groups, regulating a subset of ceramide 
species. For instance, CerS2 uses C22-C24-acyl-CoAs, whereas CerS5 and -6 use C16-CoA 
(Laviad et al., 2008; Riebelling et al., 2003 and Mizutani et al., 2005). Very recent 
experiments with chimeric proteins show that eleven residues determine the acyl chain 
specificity of CerS. Those residues are located in a loop between the last two transmembrane 
domains, with a shorter loop necessary for very-long-chain acyl-CoAs (due to a more open 
conformation of the protein) (Tidhar et al., 2018).  
All of the mammalian CerSs except CerS1, display, in addition, a homeodomain (or 
Homeobox (Hox)-like domain, Hox-domain). The Hox-domain is generally known to 
mediate DNA and RNA interactions in a variety of proteins and organisms (Dubnau and 
Struhl, 1996). For CerS, it was shown that the major portion of the Hox domain (residues 1 
to 34) is generally variable. Conservation is higher in the distal portion of the Hox-domain 
sequence enriched in positively charged amino acids. It is believed that the last stretch of 
amino acids within the homeodomain and flanking the TLC domain is necessary for the 
stability and enzymatic activity of the protein (Mesika et al., 2007; Levy & Futerman, 2010). 
Thus, it had been concluded that the homeodomain in CerS is unlikely to function as a 
genuine transcription factor (TF) (Levy and Futerman, 2010) and it more likely had a role in 
modulating CerS activity without playing a role in acyl chain specificity (Mesika et al., 
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2007). However, in a 1-hybrid system, the isolated CerS homeodomain was shown to be 
able to bind DNA, suggesting that it did not lose its DNA-binding capacity (Noyes et al. 
2008). It is nevertheless classified in several studies as CERS homeobox gene class (Holland 
et al., 2007, Bürglin & Affolter, 2016). Schematic of protein structure in Figure 1.2 (Sociale 
et al., 2018).  
 
Figure 1.2. Putative Schlank protein topology. A) Gray boxes indicate TM domains, blue marks the 
homeodomain and its helices, and in green the lag1p motif (catalytic domain). 
 
Even though CerSs and alteration of ceramide levels have been extensively studied in the 
last years, regulatory mechanisms are still lacking. Altogether, the specific function of the 
homeodomain in CerS has largely been neglected, and information on whether the 
homeodomain has a function in transcriptional regulation is missing. 
 
1.3 Ceramide Synthase subcellular localization and regulation 
 
CerSs are mainly localized to the ER (van Meer & Lisman, 2002), and very recently their 
localization at the inner nuclear membrane (INM) has been proved in both Drosophila and 
Danio Rerio (Voelzmann et al., 2016 and Mendelson et al., 2017). Unpublished data on the 
Drosophila CerS, using scanning-N-glycosylation mutagenesis (based on the evidence that 
only ER-faced regions are glycosylated) point to an N-terminus facing the ER-lumen and 
the C-terminus facing the cytosol, resulting in an uneven number of TMDs (7), with the 
homeodomain facing the cytosol (Anna-Lena Wulf, PhD thesis). 
In mammals, CerSs are differentially expressed in different tissues, with overlapping 
expression patterns for more than one CerS (Levy and Futerman, 2011). However, the 
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sphingolipid acyl-chain composition does not always correlate with CerS expression 
(Mullen et al., 2011). CerS can be phosphorylated, glycosylated, and it was shown that CerS 
could form both homo- and heterodimers (Sridevi et al., 2009, Mizutani et al., 2006 and 
Laviad et al., 2012). CerS knockdown (KD) in cell culture experiments causes changes 
(mostly upregulation) in non-targeted CerSs (Hannun and L. M. Obeid, 2011). Similarly, in 
vivo, with an inactive CerS2 (CerS2 H/A mice), expression levels of CerS5 and CerS6 were 
increased. These findings, presume a compensatory mechanism to keep overall ceramide 
levels constant or to avoid toxic accumulation of substrates (Bickert et al., 2018).  
CerS like-homeodomains are classified together with HNF (hepatocyte nuclear factor), 
TALE (transcription activator-like effectors), and ZF (zinc finger) due to the similarity in 
expression pattern according to gene expression data analysis of embryonic development in 
mouse (Dunwell and Holland 2016). Recently, genome-wide association studies identified 
a missense coding single-nucleotide polymorphism (SNP) (E115A) within the homeobox of 
the CerS2 gene. This SNP might be associated with indicators of insulin resistance or 
impaired glucose tolerance (Raichur et al., 2014). A subsequent publication showed that 
transcriptional activation of acid ceramidase (ASAH1) in mammals is not mediated by 
ceramide itself and did not depend on CerS6 catalytic activity. Moreover, every CerS (2-6) 
but CerS1 (lacking the homeodomain) was able to affect the regulation of ASAH1 (Tirodkar 
et al., 2015), suggesting a functional role for CerS homeodomain.  
 
1.4 Drosophila Ceramide Synthase Schlank  
 
Contrary to mammals, in Drosophila, only one gene is encoding for one CerS. This gene 
is named Schlank (“slim” in German), after the observation that different mutant alleles for 
Schlank affected fat storage causing a slim phenotype. In those mutants, different genes 
involved in lipid metabolism resulted in deregulated expression, such as lipase3 (lip3) a 
Triacylglycerol lipase (Bauer et al., 2009). These data provided evidence that Schlank, 
besides synthetizing ceramide, can regulate lipogenesis and lipolysis during larval growth, 
suggesting a novel role for CerSs in regulating body fat metabolism. However, not every 
phenotype of the Schlank mutants could be explained by the loss of ceramide synthesis. 
Partial rescue of the mutant´s defects was obtained when a catalytically inactive Schlank 
(carrying a mutation in one of the conserved histidines, position 215) was overexpressed in 
the genetic background of the mutants. These findings pointed to a possible homeodomain 
function. Although the possibility that Schlank could act as transcriptional regulator via the 
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homeodomain is quite tempting, this would suppose a nuclear function and a nuclear Schlank 
pool.  
 
1.5 Schlank nuclear localization and nuclear function 
 
The nucleus is a highly compartmentalized organelle. The nuclear envelope (NE) consists 
of an outer nuclear membrane (ONM), in continuous with the ER, and an inner nuclear 
membrane (INM). The INM can form invaginations able to reach the nucleoplasm, framing 
in this way a nucleoplasmic reticulum (Malhas et al., 2011). The INM harbors a unique set 
of membrane proteins, many of which interact with intermediate nuclear filaments and 
chromatin components and thus play an essential role in nuclear organization and gene 
expression regulation (Zuleger et al., 2012). The NE covers the nucleus entirely except 
where nuclear pore complexes (NPCs) are inserted. Transport receptors (Importins α/β) 
mediate nuclear import interacting with cargo proteins via nuclear localization signals 
(NLSs) on the cargo.  
Very recently, it was shown that endogenous Schlank protein is also localized at the INM, 
in Drosophila Schneider cells (S2) and fat body cells. To prove Schlank nuclear localization, 
several Schlank constructs fused with a green fluorescence protein (GFP) were 
overexpressed in S2 cells. Schlank Full length-GFP protein (amino acids (aa) 1-400) was 
found to localize at the ER and the nucleus. Next, the N-terminal portion of the protein (aa 
1-138) that included, according to prediction, the first TM and the homeodomain with a GFP 
was used in S2 cells experiments. The GFP signal for this Schlank variant was found to 
accumulate to the nucleus. The strongest nuclear signal was associated with GFP-
homeodomain fusion proteins containing the homeodomain only (GFP-Schlank aa73–133) 
or the complete stretch between the first two potential transmembrane domains (GFP-
Schlank aa64–138) including newly found NLS sequences (NLS1, RPKK, aa78–81, and an 
atypical bipartite-like NLS2, RLDKKK-X19-RLRR, aa97–125) within the Schlank 
homeodomain. When NLS1 (ΔRPKK) or part of NLS2 (Δaa119–125) was deleted, the GFP 
homeodomain fusion protein (aa 64-138 ΔNLS) was detected mainly in the cytoplasm and 
hardly detected in the nucleus. A scheme for homeodomain and NLS sites is shown in Figure 
1.3. 
Moreover, by RNA interference (RNAi) in clonal analysis in fat body cells, was proved 
that the two NLSs are recognized by Ketel, the Drosophila homolog of Importin-β, and 
needed for the nuclear import. More importantly, appeared clear that the nuclear function of 
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Schlank is required for the regulation of fat metabolism and acts independently from the 
catalytic activity of the protein. This was demonstrated through overexpression of several 
Schlank variants in rescue experiments of the previously mentioned Schlank allele mutants 
(P-element mutants). Oppositely to the expression of several Schlank variant (included a 
deficient catalytic activity variant), the expression of an NLS2 mutant Schlank variant failed 
to rescue lip3 overexpression (Voelzmann et al., 2016). 
 
Figure 1.3. Schematic of homeodomain and 
NLSs. A) Monopartite-like NLS1 (RPKK, aa 78–
81) and atypical bipartite-like NLS2 (RLDKKK-
X19RLRR, aa 97–125) are depicted above the 
homeodomain. 
 
 
1.6 The fate of fat 
 
Under normal feeding conditions, dietary lipids, such as triacylglycerols (TAG), are 
broken down into free fatty acids (FFA) and monoacylglycerols (MAG) in the intestinal 
lumen. These digested lipids can then be absorbed by the intestinal cells, where the TAGs 
are resynthesized and packaged together with cholesterol, cholesterol esters, and carrier 
proteins to form lipoprotein particles. These lipids can be either utilized by cells or deposited 
as lipid droplets (LD) in storage tissues, as the fat body organ in Drosophila or the adipose 
and liver in mammals. The larval fat body, for instance, serves as a dynamic source for 
maintaining energy homeostasis and as a reservoir for stored lipids during the prolonged 
period of non-feeding (caused by nutrient deprivation or during metamorphosis) (Sieber and 
Thummel, 2009). At times of demand, fatty acids (FA) are released from cellular LDs by the 
action of TAG hydrolases or lipases, shifting the animal metabolism to lipolysis. 
Unesterified fatty acids or FFAs are biomolecules that serve multiple functions. FA 
represent constituents of essentially all lipid classes, regulate gene expression by acting 
directly or indirectly as ligands/cofactors for nuclear receptors, affect protein function by 
post-translational acylation of target peptides, and, above all, serve as the most energy-dense 
substrate in the body for the production of ATP via β-oxidation. However, excessive cellular 
concentrations of FFAs are toxic to cells and tissues. Because of their amphipathic nature, 
FFAs act as detergents, damage cell and organelle membranes, and perturb the cellular acid-
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base homeostasis. To avoid toxicity, FFAs are re-esterified with glycerol, and the resulting 
TAG are then deposited in LDs in every cell of the body. Accordingly, TAG stores function 
as buffer for incoming lipids to prevent lipotoxic concentrations of FFAs (Lusis and 
Pajukanta, 2008). Thus, these mechanisms need to be tightly controlled and orchestrated to 
maintain lipid homeostasis and growth.  
Simultaneously, a small fraction of FA is used by the sphingolipid biosynthetic pathway 
for the production of ceramide and complex sphingolipids. In the context of ceramide 
synthesis, FAs and specifically medium chain fatty acids (MCFA) are needed in two steps 
of the pathway (Figure 1.1). The initial step of the reaction is the condensation of serine with 
palmytoil-CoA (C14) operated by Serine palmitoyltransferase (Spt) to form sphinganine. 
CerS then catalyze the N-acylation between the sphinganine backbone and fatty acyl-CoA 
of different chain length (C-n). In Drosophila mainly C14 activated fatty acids are linked to 
sphinganine for the production of ceramide (Bauer et al., 2009). Ceramide imbalance in 
tissues has been implicated in the impairment of many metabolic processes.  
 
1.7 Ceramide lipotoxicity 
 
Ceramide lipotoxicity has been shown to affect almost every cell or tissue type examined 
so far, causing a wide range of effects in a cell-type- specific and context-dependent manner. 
In fact, alteration of ceramides have been involved in both insulin tolerance and insulin 
resistance (Shimabukuro et al., 1998; Shulman et al., 2014 ), obesity associated with low-
level of inflammation (Goldberg et al., 2015; Youm et al., 2011), protection or induction of 
steatohepatitis (Turpin et al., 2014; Xia et al., 2015; Raichur et al., 2014), atherosclerosis 
(Glaros et al., 2008), and cardiomyopathy (Walls et al., 2018; Goldeberg et al., 2012; Russo 
et al., 2012). 
Numerous lipidomic and inflammasome analysis of plasma sera detected a correlation 
between plasma ceramides alteration and most of the pathologies described above. The fact 
that ceramides are biosynthetic intermediates that do not exist in a steady-state concentration 
and composition represents a challenge in interpreting this profiling. Although most of the 
metabolic disorders are associated with increased food uptake, little is known about how 
ceramides fluctuate in response to feeding or other environmental factors.  
An understanding of the mechanisms on how ceramides are regulated and how ceramides 
regulate physiological and pathological events in specific cells may provide new targets for 
therapeutic intervention. 
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1.8 Aim of the thesis 
 
Despite the abundance of publications on CerSs, the exact mechanisms of how ceramide 
synthesis is regulated and on how CerS activity is modulated is to date still far beyond clear. 
Most of the publications only deal with the effect on altered ceramide levels on physiological 
and pathophysiological processes not investigating the regulatory mechanisms. Although it 
became clear during the last years that not only the enzymatic activity plays essential roles 
in cellular processes but rather the protein itself, the possible homeodomain function is still 
ignored. 
By using the first established in vivo animal models for the homeodomain (Anna-Lena 
Wulf, Ph.D. thesis), this thesis aimed to identify the homeodomain function in vivo and its 
role in regulating fat metabolism.  
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2 Results 
2.1 Schlank in vivo models to investigate domain-specific function  
 
To study the homeodomain function in vivo, homologous recombination and phage φC31 
integrase based genomic engineering approach was used (Anna-Lena Wulf, Ph.D. Thesis). 
The Schlank gene (exon 2 to exon 6) was replaced by homologous recombination with attP 
sites generating a SchlankKO  
(KO) line. Next, target constructs containing the deleted genomic Schlank DNA were 
reintegrated. The reintegrated DNA without (WT) and with a point mutation either in the 
NLS1 site, or NLS2 site, or E118A of the homeodomain or in the catalytic domain (H215D) 
were reintegrated into the native Schlank locus in the SchlankKO founder line (Figure 2.1) 
(Sociale et al., 2018). Reintegration of the target constructs restored the target locus, qRT-
PCR (quantitative Real-Time Polymerase Chain Reaction) analyses revealed that the 
transcript levels of Schlank and of genes within or close to its genomic locus were similar in 
Schlank knock-in (KI) wild-type (KIWT), SchlankKINLS2 (KINLS2), SchlankKINLS1 (KINLS1), 
SchlankKIH215D (KIH215D), SchlankKIE118A (KIE118A), and w1118 control animals (Sociale 
et al., 2018, Appendix Figure A5.1, A). This confirmed the expression of reintegrated 
genomic DNA. 
The mutation in KINLS1 affects the monopartite-like NLS1 site (RPKK, 80-81), located 
at the beginning of the first helix with the homeodomain, where two positively charged 
amino acids are exchanged with two non-charged amino acids (RPKK to RPMM). The 
mutation in KINLS2 affects the portion of the bipartite-like NLS2 (RLRR, 122-124) site 
residing in the third helix of the homeodomain. In this case, two positively charged amino 
acids are substituted with two negatively charged ones (RLRR to ALAR). Those two 
mutations were chosen because they altered Schlank nuclear localization in cell culture 
experiments. The mutation E118A in the KIE118A mutant is the Drosophila homologous of 
a SNP (E115A) found in human CerS2, associated with diabetes and insulin resistance. This 
mutation was not tested for localization in cell culture experiments. The mutation H215D in 
KIH215D mutants abolishes the catalytic activity of the protein. 
 
 11 
 
 
Figure 2.1. Schematic representation of genomic engineering. A) Schlank gene is formed by 6 exons that 
are regulated by splicing. The area targeted for homologous recombination corresponds to part of the first 
intron and the following gene spx. The first exon and intron are not targeted because of the presence of CG3781 
gene coding for a protein with ubiquitin protease activity. B) Schlank locus after targeting, exons 2-6 replaced 
by attP site (KO). C) Diagram showing the reintegration of the deleted WT gDNA to generate KIWT or D) 
with a mutation in the coding region of the catalytic domain from histidine (H) into Aspartic Acid (D) in 
position 215 (HH>HD) that impairs the enzymatic activity. E-F-G) Diagram showing the reintegration of the 
deleted gDNA with mutations within the homeodomain coding region, in the NLS1 coding site for two to 
methionines (M) instead of two lysines (K) RPKK>RPMM to generate KINLS1. For the NLS2 coding site of 
two arginines (R) into alanine (RLRR>ALAR) to generate KINLS2 and for the homologous of a mammalian 
SNP for the coding region of the amino acid in position 118 for a alanine (A) instead of a glutamic acid (E) to 
generate KIE118A (modified from Sociale et al., 2018). 
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2.2 Phenotypical characterization of homeodomain mutants 
 
To investigate and understand the homeodomain function, an in-depth analysis of 
different Schlank KI alleles (Figure 2.1, A; G) was carried out taking advantage of the first 
established in vivo homeodomain models. A scheme of where the different mutations within 
the Schlank protein are localized is presented in Figure 2.2, A.  
 
 
Figure 2.2. Schematic of the mutations within Schlank. A) The red bars indicate where the different 
mutations are directed. Bold letters within amino acids (aa) sequence highlight the mutations. B) Schematic of 
Homeodomain monopartite-like NLS1 (RPKK, aa 78–81) and atypical bipartite-like NLS2 (RLDKKK-
X19RLRR, aa 97-102 and 122–125) are depicted above the homeodomain. The position where the E>A SNP 
is located is also depicted (EIER, aa 116-119). 
 
The above-mentioned fly lines were analyzed for survival and development, body fat 
content and Schlank nuclear localization. Since KIWT flies were not distinguishable from 
the commonly used W1118 or Oregon R- control fly regarding survival, development, fitness, 
gene expression (See Appendix, Figure A5.1, A) and any other analysed parameters, the data 
of these additional controls (W1118 and Oregon R-) have been omitted from this thesis. 
Therefore, the KIWT was used as a control in all of the experiments described here, because 
of the similarity in genetic background. 
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2.2.1 Phenotypical analysis of Schlank mutants  
 
The phenotypical analysis of KO and KIH215D mutants, showed an early larval lethality, 
proving once more CerS as center player in biological processes. Meanwhile, the 
homeodomain mutants show different degrees of developmental delay and survival rate. 
KINLS1 larvae and adults are not distinguishable from KIWT control flies (Figure 2.3, A, B), 
KIE118A show a few hours delay in reaching the pupariation stage. Generally, pupariation 
occurs on day 5 (120 h) after egg laying (AEL), when larvae are kept at 25°C. In the case of 
KIE118A, the pupation of 76% of the selected larvae occurred around 130 h AEL (Figure 
2.3, A). The hatched KIE118A adults showed a lifespan similar to KIWT and KINLS1, but 
they happened to die earlier on average (Figure 2.3, B). In contrast, the developmental delay 
and the survival rate for KINLS2 mutants were more dramatic. Notably, at day 5 AEL, 
KINLS2 mutants were still entering the second instar larval stage (L2), only around 20% of 
the counted larvae reached the pupation stage which occurred for most of them around day 
11. The few flies who managed to hatch as adult flies (~10%) showed several defects in 
motoric dysfunction, analyzed by climbing assays (Christoph Schwarzkopf, Master Thesis). 
The developmental delay of KINLS2 is not surprising considering the slimness phenotype of 
these larvae. It is well known that to undergo pupation Drosophila larvae need to reach a 
critical mass or weight (Edgar, 2006, Davidowitz et al., 2003, Nijhout, 2003). After 9 days 
(d) of larvae stage the KINLS2 larvae reach KIWT in length, but they appeared thinner 
(Figure 2.3, C; Sociale et al., 2018), resembling partially the phenotype of the previously 
published Schlank P-element mutants (SchlankG0061, SchlankG0349 ) (Bauer et al., 2009). 
 
 
 
Figure 2.3. Life Span analysis of Schlank KI alleles. A) Pupariation rate. The green and red “X” are referring 
to KO and KIH215D that do not pupariate, grey and turquoise refer to KIWT and KINLS1 respectively, that 
pupariate as WT flies, orange referrers to KIE118A showing a reduced puparation rate and a slight 
developmental delay. The blue line represents KINLS2 mutants; that show a severe developmental delay and a 
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reduced survival rate at around day nine some of the larvae reach the third instar larval stage (L3) and start to 
pupariate, mostly the survived larvae reach pupariation around 13 d AEL. B) Life span analysis; KO, and 
KIH215D die during the first 48h AEL (red and green) as L1. A reduced percentage of KINLS2 (blue) hatch as 
a small sized adult, showing motoric dysfunction and mostly die within the first ten days of life as adults, 
KIE118A (orange) also show a small reduction of life span when compared to KIWT and KINLS1 (grey and 
turquoise). C) Monitoring of food intake by feeding red-colored yeast and phenotypical analysis of mutant 
larvae. KINLS2 show developmental delay and a slimness phenotype when morphologically reaching the L3 
stage (e.g., 9 d) (analysis of anterior and posterior spiracles, See Materials and Methods, 4.2.1). 
 
2.2.2 Analysis of body fat homeostasis 
 
To exclude that the difference in body fat was merely due to a difference in food uptake, 
the larvae were fed with red-colored yeast (Figure 2.3, C), showing non-altered food uptake. 
As mentioned above, TAGs are the primary form of stored lipid in the fat body organ in 
Drosophila, and TAG metabolism leads to the production of FFAs. To verify whether an 
impairment of TAG metabolism would be responsible for the slim phenotype of the mutant, 
analysis of fat body cell size, TAG and FFA content were carried out. 
No differences were observed for fat body cell size (quantification in Figure 2.4, A) and 
in the relative amount of TAG and FFA for KINLS1 and KIE118A (Figure 2.4, B, C). In 
contrast, KINLS2 mutants showed an easily noticeable difference in cell size, with KINLS2 
cells more than 50% smaller than KIWT. Representative image for KIWT and KINLS2 are 
shown in the Appendix Figure A5.2, A. Interestingly, when using the FLP/FRT system to 
perform clonal analysis in fat body cells, the overexpression of a full-length wild-type 
Schlank variant in the background of KINLS2 significantly increased cells size while 
overexpression of SchlankRNAi managed to reduce cells size even more. The direct conclusion 
of these findings is that Schlank can regulate size in a cell-autonomous way. This might be 
dependent on the homeodomain function since the overexpression of SchlankNLS2 (NLS2-
HA) did not influence cell size (Benjamin Franz Syllwasschy, Bachelor Thesis). Moreover, 
the analysis of body fat content confirmed a reduction in TAG levels and an increase in FFA 
levels for KINLS2 mutants (Figure 2.4, B, C). 
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Figure 2.4. Analysis of cell size and body fat. A) Reduced cell size in KINLS2. Representative image for 
KIWT and KINLS2 are shown in the Appendix Figure A5.2, A. B) Relative TAG quantification normalized to 
dry weight show a reduction in the TAG for KINLS2 mutants in accordance with the phenotype. C) Relative 
FFA normalized to protein concentration showed an increase in FFA for KINLS2 mutant. Error bars indicate 
SEM, **p < 0.01, and ***p < 0.001. 
 
Stored TAG are broken down by lipases in glycerol and FFA, these can then be utilized 
to gain energy through mitochondrial β-oxidation. For this reason, the transcription level of 
genes involved in lipid metabolism and particularly in lipolysis was examined. 
In the past years, several lipases have been studied in the context of lipid homeostasis and 
linked to body fat regulation in Drosophila. The lipases CG6295 (Palanker et al., 2009), 
CG6277 and CG8093 (Nirala et al., 2012), brummer (bmm) (Grönke et al., 2005) were 
chosen because associated with reduced TAG levels. Despite being a gastric lipase, magro 
was tested because it is linked with reduced body fat (Sieber and Thummel, 2009). Lipase3 
(lip3) was also examined because strongly upregulated in SchlankG0061 mutants. Moreover, 
in these mutants lip3 could be repressed upon overexpression of a Schlank WT variant 
(Bauer et al., 2009).  
In agreement with the observed TAG reduction and increased FFA, qRT-PCRs revealed 
an increase of lip3; CG6295; CG6277; CG8093 and magro transcripts in KINLS2 larvae, but 
not in KIE118A and KINLS1 (Figure 2.5, A, B). The lipase bmm, not deregulated in KINLS2 
mutants, together with lip3 are responsive to starvation (Zinke et al., 2002; Grönke et al., 
2007) and have been used in combination with other components of the insulin signaling 
pathway (ILS) as starvation markers. The Insulin signalling starts with the secretion from 
the brain of Drosophila insulin like peptides (DILPs) that as extracellular ligands, bind to 
the Insulin Receptor (InR), initiating a phosphorylation cascade and through Akt 
(serine/threonine-specific protein kinase (PKB)) inhibit the transcriptional activity of Foxo 
(the main effector TF of ILS).  
In a food-deprived situation, Foxo remains constitutively active and regulates the 
translational regulator 4E-BP (eukaryotic initiation factor 4E binding protein, thor in 
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Drosophila) and InR itself, providing a feedback mechanism and regulating different genes 
including bmm. To exclude any impairment of the ILS, starvation response genes such as 
InR, thor, bmm and several others were tested in KINLS2 mutants. Genes involved in ILS 
were not transcriptionally upregulated in KINLS2 larvae (Figure 2.5, C). However, their 
expression could be induced upon starvation (Figure 2.5, E), indicating a normal starvation 
response.  
Moreover, the expression of factors involved in lipid homeostasis as SREBP (sterol 
regulatory element binding protein) and DHR96 (Drosophila hormone receptor 96) 
responsive to Cholesterol, and FAS (fatty acid synthase) was also analyzed by qRT-PCR. 
Although SREBP and DHR96 were not affected in transcriptional regulation, the expression 
of FAS was moderately increased (Figure 2.5, F). 
 
 
 
Figure 2.5. Analysis of gene involved in TAG metabolism and ILS. A) Lipases expression in KINLS1 and 
KIE118A normalized to KIWT gene expression. B) Lipases expression in KINLS2 normalized to KIWT gene 
expression, any of the lipases tested resulted chronically upregulated. C) Genes involved in ILS in KINLS2 are 
 17 
normally expressed, normalized to KIWT gene expression. D) Analysis of starvation response for genes 
involved in ILS for KIWT, KINLS1, KIE118A and KINLS2 E) show an unaltered response to starvation 
normalized to KIWT gene expression for starved KINLS1, KIE118A and KIWT, normalized to KINLS2 for 
starved KINLS2 (E). F) Relative expression of genes involved in lipid homeostasis show normal expression 
levels for SREBP and DHR96, but an upregulation in FAS for KINLS2 normalized to KIWT gene expression. 
Transcript levels were quantified using qRT-PCR (normalized to rp-49). Error bars indicate SEM. *p < 0.05, 
**p < 0.01, and ***p < 0.001. 
 
Fatty acid biosynthesis and breakdown occur by different pathways, are catalyzed by 
different sets of enzymes, and take place in different compartments of the cell. When a cell 
or organism has more than enough metabolic fuel to meet its energy needs, FAS is 
overexpressed to convert the excess of fuel in FAs, and subsequently they are converted into 
TAGs. For these reasons, the de novo rate of TAG and FA was also measured. Accordingly, 
de novo TAG synthesis was reduced, while in contrast FA synthesis was slightly increased, 
supposing an alteration of FA catabolic and metabolic processes in KINLS2 (Figure 2.6).  
 
Figure 2.6. Analysis of lipogenesis.  
Metabolic labeling experiment in 
larvae using [1-14C]-acetic acid to 
determine TAG and FA generation. 
Equal amounts of radioactivity were 
applied to TLC plates, and percentage 
of the incorporated label was 
quantified. Biosynthesis of TAG is 
reduced in KINLS2 mutants whereas 
generation of FA is increased. No 
change is observable for KINLS1. This 
data are not yet available for KIE118A. Error bars indicate SEM. *p < 0.05, **p < 0.01, and ***p < 0.001. 
 
These pathways are regulated at the level of gene expression although the detailed 
mechanism by which these genes are regulated is not yet clear. However, if FA synthesis 
and TAG breakdown were proceeding simultaneously, like in the case of KINLS2 mutants, 
the two processes would constitute a futile cycle, simply causing a waste of energy. This is 
confirmed in KINLS2 by low ATP levels and hyperphosphorylation of AMPK, a well-known 
cellular energy sensor (Azim M. Sarker, Master Thesis).  
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2.2.3  De novo Ceramide Synthase activity  
 
To rule out the impact of the enzymatic function of the protein on any of the observed 
phenotypes, a de novo ceramide synthase assay was performed. First instar larvae were 
selected and kept on standard food until 48h AEL. After this time, radioactive acetate mixed 
with inactivated yeast was fed for 18h. Subsequently, lipids were extracted and TLC (Thin 
Layer Chromatography) was performed (Dr. Bernadette Breiden). Unexpectedly, the de 
novo ceramide synthesis rate was reduced for KINLS1 but resulted unchanged for the 
KINLS2 mutants (Figure 2.7, A). Meaning that the phenotypes of KINLS2 mutants were 
exclusively linked to the Schlank homeodomain and strengthening its function in relation to 
body fat homeostasis. 
 
Figure 2.7. Analysis of de novo CerS. A). Metabolic 
labeling experiment in larvae using [1-14C]-acetic 
acid to determine de novo ceramide generation. Equal 
amounts of radioactivity were applied to TLC plates, 
and percentage of the incorporated label was 
quantified. Biosynthesis of ceramide in KINLS2 
mutants showed no difference in comparison with 
KIWT controls, while KINLS1 shows reduced de novo 
ceramide synthesis. This data are not yet available for 
KIE118A. Error bars indicate SEM. *p<0.05. 
 
2.3 Schlank nuclear function and transcriptional regulation 
 
Each of the mutant fly lines was tested for impairment of nuclear localization in fat body 
cells of L3 larvae (Figure 2.8, A). Previously it was shown that the NLS2 and NLS1 sites 
are necessary for nuclear localization in cell culture experiments and that mutation of the 
NLS2 site resulted in the loss of Schlank nuclear function in lipid homeostasis in P elements 
mutants (Voelzmann et al., 2016). For KINLS1 and KIE118A mutants, no difference in 
nuclear localization was observed. Considering the severity of KINLS2 phenotypes, a 
complete ER retain for Schlank carrying the NLS2 mutation was expected. Instead, Schlank 
nuclear localization was not dramatically reduced (~15%) for KINLS2, in comparison with 
KIWT (Sociale et al., 2018). This reduction does not seem sufficient to explain all the severe 
phenotypes of KINLS2 mutants. Representative image for KIWT and KINLS2 are shown in 
the Appendix Figure A5.2, B 
* 
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Figure 2.8. Analysis of Schlank nuclear localization. A) Relative 
mean fluorescence intensities (MFIs) of nucleus/cytoplasm, 
determined in fat body cells of KINLS2 and KIWT (L3) larvae using 
α-Schlank antibody recognizing the C-Terminal of the protein (α-
Schlank CT). Cells were stained for Lamin Dm0 to mark the nuclear 
membrane, Spectrin to mark cell membrane and DAPI. 
Representative image for KIWT and KINLS2 are shown in the 
Appendix Figure A5.2, B. Error bars indicate SEM, *** p<0.001. 
 
2.3.1 Extensive framework of deregulated gene expression 
 
Following the data pointing to deregulated transcriptional response (Figure 2.5 B, E, F), 
genome-wide transcriptome data of the fat body of KINLS2 and KIWT L3 larvae using 
quantitative RNA-sequencing (RNA-seq) were generated and followed by bioinformatics 
analysis (in collaboration with AG Schultze).  
An unbiased principle component analysis based on all 10,760 present genes and 
hierarchical clustering on the 1,000 most variable genes revealed significant transcriptional 
changes between KIWT and KINLS2 mutants. Using a one-way ANOVA-model, 
differentially expressed genes between the two conditions were determined, and the fold 
changes against the p-values were plotted in a volcano plot (Figure 2.9, A). 664 genes were 
significantly up- or downregulated with a fold change of ≥3 and a p-value of 0.05. The 
majority of genes was upregulated in KINLS2 (503 genes). The topology of variable genes 
between KIWT and KINLS2 mutants is visualized by mapping the fold change among the 
two conditions onto the nodes of the network, representing the genes. Highlighting the 664 
significantly up- and downregulated genes revealed two distinct clusters of co-expressed 
genes (Figure 2.9, B). 
Furthermore, the 10 genes with the highest and lowest fold changes were used to identify 
their nearest neighbours in the co-expression network and gene ontology enrichment 
analyses on the two resulting gene sets were performed. A significant enrichment for genes 
downregulated in KINLS2 and their neighbours was not detected, but a list of significantly 
enriched GO-terms was determined for the gene set based on the genes upregulated due to 
the NLS2 mutation (Figure 2.9, C). Interestingly, all significantly enriched GO-terms 
describe metabolic processes and show a striking overrepresentation of terms associated with 
lipid metabolism, matching the phenotype observed for the mutant animals and underlining 
 20 
the relevance of Schlank in this regard. Taken together, the RNA-seq analysis revealed a 
substantial impact of the NLS2 mutation on transcription. 
 
 
 
 
Figure 2.9. Altered gene expression in KINLS2 mutants. A) Volcano plot of all present genes. Genes 
significantly up- or downregulated (fold change |FC| > 3; p-value < 0.05) in KIWT over KINLS2 mutants are 
marked in red. Sorted by fold change the gene symbols of the most up and downregulated genes were added 
to the plot. B) Using the same dataset, a coexpression network was calculated. Genes significantly upregulated 
in KINLS2 mutants were marked in red, while downregulated genes were coloured in blue. Gene symbols of 
the most regulated genes were added to the plot. C) The 20 most up- and down-regulated genes together with 
their nearest neighbours taken from the co-expression network (Figure 2.9; B) were used to perform a gene 
ontology enrichment analysis. Significantly enriched GO terms for genes upregulated in KINLS2 are listed 
according to their fold enrichment. 
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2.3.2 DNA binding mediates transcriptional regulation 
 
It is possible to hypothesize from qRT-PCRs, RNA-seq data, and from the mild 
reduction in nuclear localization in KINLS2 mutants that a functional Schlank 
homeodomain is needed to regulate transcription. Although previous publications 
questioned that CerS homeodomain might act as a transcriptional regulator, the modelling 
of the Schlank homeodomain revealed that the folding corresponds to the standard DNA 
binding architecture of homeodomain like transcription factor as the well-known 
Drosophila Ubx (André Voelzmann, Ph.D. Thesis; Sociale et al., 2018). Moreover, 
scanning promoter regions of lip3 and magro for Schlank binding site (described by 
Noyes et al., 2008; JASPAR database) showed several binding sites for the putative 
Schlank consensus (Sociale et al., 2018) (Figure 2.10, A, B). 
 
 
 
Figure 2.10. Schlank binding consensus. A) Schlank consensus obtained by JASPAR database based on 
position frequency matrices (PFMs) and TF flexible models (TFFMs) of TFs across multiple species from six 
taxonomic groups. B) Scanning of lip3 and magro gene locus for Schlank binding consensus. The bars indicate 
different Schlank binding consensus within the lipases regulatory regions but also within the gene locus. The 
green bars identify the sites amplified in the experiments described below (ChIP). 
 
To verify whether Schlank might be able to bind DNA, Chromatin Immunoprecipitation 
(ChIP) assay was established. For the simplicity of the system, S2 cells were used to perform 
every ChIPs.  
Firstly, ChIP was performed with two different Schlank specific antibodies on 
endogenous Schlank; the fist one recognises the beginning of the homeodomain (α-Hox), 
while the second one recognises the C-Terminal part of the protein (α-CT). Pull down with 
an α-Histone H3 was chosen as a positive control (Histone proteins are bound almost 
everywhere in the genome) and as a negative control for the immunoprecipitation (IP), an α-
 22 
IgG antibody was used. Every ChIP always included an Input sample representative of the 
whole DNA extract. 
Linker-mediated PCR was considered to be the first and more immediate way for the 
visualization of the IP results. Linkers were ligated to the whole pull down and used for 
amplification by PCR. Subsequently, the pull-down was amplified with lip3 or magro 
specific primers (randomly chosen site among the different ones found by JASPAR scanning 
tool with a matrix score higher than 90%; green bars in Figure 2.10, B). Afterward, the PCR 
samples were run on an agarose gel. It is possible to notice in Figure 2.11, A, that, among 
all of the unspecific bands, a band of the right size (~100 bp) appeared in every sample 
except the for IgG sample, where no band was present. Afterward, the same set of primers 
was used for qRT-PCR. Primers for negative controls were also included, amplifying regions 
of sprouty (sty) (commonly used as negative control for ChIP in Drosophila, Xu et al., 2012). 
The expression fold for each amplified gene in the IP was normalized on its IgG expression 
fold. In Figure 2.11 B, it is possible to appreciate that there is an enrichment of lip3 and 
magro promoter for the pull down of Schlank α-CT and Schlank α-Hox in comparison with 
the negative control sty. No enrichment for lip3 and magro regulatory regions is present in 
the Input and H3 samples, meaning that they were selectively pulled down by Schlank 
specific antibodies. These results prove not only that Schlank homeodomain could bind 
DNA, but also that the whole transmembrane protein is involved in the regulation at the 
DNA.  
Next, the impact of the different mutations on DNA binding was analysed. To this end, 
different Schlank mutant variants fused with a hemagglutinin tag (HA-tag) were 
overexpressed in S2 cells (pUAST-Schlank-HA vectors were cotransfected with pAc-GAL4 
vector), UAS-SchlankWTHA (WT-HA), UAS-SchlankNLS2-HA (NLS2-HA), UAS-SchlankNLS1-HA 
(NLS1-HA) (Bauer et al., 2009; Voelzmann et al., 2016), and the newly generated UAS-
SchlankE118A-HA (E118A-HA) and UAS-SchlankH215D-HA (H215D-HA), also to rule out any 
impact from the catalytic domain on DNA binding. Confirming the results of the ChIP 
experiments on the endogenous Schlank, an enrichment in regulatory regions of lip3 and 
magro was observed when precipitating the WT-HA. No difference was observed regarding 
the DNA binding capabilities of NLS1-HA, E118A-HA, and H215D-HA proving that the 
homeodomain function is also independent of the enzymatic activity of the protein (Figure 
2.11, C). In contrast, NLS2-HA failed to precipitate regulatory regions of lip3 and magro 
since no enrichment was observed in comparison to the negative control sty (Figure 2.11, 
D). Furthermore, in-depth bioinformatics studies revealed that the NLS2 mutations are 
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overlapping with the putative DNA-binding region in the third helix of the homeodomain, 
and particularly that the mutated Arginine in position 122 is described as a critical residue 
for sequence-specific DNA-binding of Hox-domains (Bürglin and Affolter, 2016).  
 
 
 
Figure 2.11. Schlank binds lip3 and magro promoter regions. A) Analysis of Schlank pull down (ChIP) 
material from S2 cell extract by linker-mediated-PCR, using α-Hox, α-CT, α-IgG, and α-H3 antibodies as 
negative and positive controls, respectively. The Input sample is representative of the initial amount of DNA. 
The square bracket highlights unspecific bands while the arrow indicates the expected, specific 120bp band 
(representative amplification for magro promoter region). B) Quantification by qRT-PCR of ChIP; promoter 
regions assayed were those of lip3, magro, and sty (negative control). Expression was normalized to the relative 
expression of the IgG sample (n = 3). C) Quantification by qRT-PCR of ChIP material from S2 cell extract 
transfected with HA-WT, E118A-HA, NLS1-HA and H215D-HA (n = 3) using α-HA antibody. The mutations 
do not affect DNA binding since lip3 and magro regulatory regions result enriched in comparison with sty. D) 
NLS2-HA IP does not pull down selectively and in an enriched fraction lip3 and magro regulatory regions in 
comparison with sty (n = 4). The Positive control used is WT-HA. Error bars indicate SEM, * p<0.05. 
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2.3.3 Schlank DNA binding is necessary to repress lip3 in vitro and in vivo 
 
To gain more information about the transcriptional regulation and to further prove 
Schlank DNA binding properties, luciferase reporter assay was performed. A lip3 upstream 
regulatory region (1.7 kb) was cloned into a firefly-luciferase reporter assay plasmid 
(Dominic Peters, Bachelor thesis). S2 cells were cotransfected with the lip3-firefly, the 
Schlank variant of interest and with a Renilla luciferase control reporter. The system was 
tested by overexpression of WT-HA, SchlankRNAi, and an unrelated TF UAS-AP-2 (AP-2). 
As general control, an UAS-nuclearGFP (neGFP) was used. As shown in Figure 2.12 A, the 
overexpression of the unrelated TF AP-2 did not change lip3 reporter activity. In contrast, 
HA-WT strongly repressed lip3 reporter activity while an increase in luciferase activity was 
observed when SchlankRNAi was overexpressed. These results confirm the hypothesis 
postulated in previous publications (Bauer et al., 2009; Voelzmann et al., 2016) that Schlank 
is needed for the repression of lip3. This regulatory mechanism would be in accordance with 
several publications on Hox protein showing that they act as repressors, particularly during 
development (Gabelein et al., 2004; Agelopoulos et al., 2012). 
Next, the impact of the different mutations (NLS1-HA, E118A-HA, H215D-HA, and 
NLS2-HA) on lip3 reporter activity was evaluated. In accordance with ChIP results the 
overexpression of either NLS1-HA, E118A-HA, H215D-HA where the DNA-binding 
capability is not affected (Figure 2.11, C), could repress lip3 luciferase activity (Figure 2.12, 
B). However, when NLS2-HA, mutation that abolishes DNA binding (Figure 2.11, D) was 
overexpressed, the suppression of lip3 reporter activity was lost (Figure 2.12, B). In 
conclusion, these data provide evidence that the DNA binding mediated via the NLS2 site 
within the homeodomain is required for transcriptional regulation (Figure 2.12, B). 
Moreover, these experiments suggest that the NLS2 mutation has a dominant negative effect 
on transcriptional regulation.  
The NLS2 site is conserved in all the mammalian CerSs (mCerSs) except CerS3, which 
nevertheless still contains the two arginines that are mutated in the NLS2 mutants 
(Voelzmann et al., 2016). Alignment for NLS2 site is shown in Appendix Figure A5.7, A.  
Therefore, a mammalian homeodomain-containing CerS was tested for the ability in 
regulating lip3 expression. CerS2 was chosen because it was already proven to be able to 
rescue Schlank P-element mutants (Bauer et al., 2009). Thus, HA-CerS2 and newly 
generated CerS2-NLS2-HA carrying a mutation in the NLS2 (RRRR to ARAR) and CerS2-
H215D-HA carrying a mutation in H215D, were generated and tested in the luciferase 
reporter system (Figure 2.12, C). The expression of both WT-HA and H215D-HA CerS2 
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variants resulted in a repression of the lip3 reporter activity, while CerS2-NLS2-HA failed 
to repress lip3 luciferase activity (Figure 2.12, C) comparably to Schlank variants (Figure 
2.12, B). Thus, these data show that the mammalian CerS2 could also regulate transcription 
and that the NLS2 site would be indeed conserved and required for this function. 
 
 
 
Figure 2.12. Schlank represses lip3 transcription. A) A 1.7 kb lip3 enhancer was introduced into a luciferase 
reporter plasmid containing an actin basal promoter and firefly luciferase (lip3 reporter). Relative luciferase 
induction upon expression of neGFP, unrelated TF AP-2, WT-HA, and SchlankRNAi is indicated, normalized to 
Renilla luciferase control transfection (n= 3). B) Relative luciferase induction upon expression of either WT-
HA, NLS1-HA, E118A-HA, or H215D-HA, suppresses luciferase activity, while expression of NLS2-HA 
increases lip3 reporter activity (n = 3). C) Relative luciferase induction upon expression of either HA-CerS2, 
CerS2-H215D-HA, or CerS2-NLS2-HA (n = 3), the mutations in mCerS2 behave as Schlank on lip3 reporter 
activity. Error bars indicate SEM, *** p<0.001, ** p<0.01,* p<0.05. 
 
To confirm these results, obtained in cell culture experiments, also in vivo, the Gal4/UAS 
system was used. Several UAS Schlank variants fly lines were crossed in the background of 
KINLS2 mutant. The expression was driven from the first hours of larval development until 
the L3 stage using a specific fat body driver (cgGAl4, Pastor-Pareja et al., 2011). The 
samples were frozen and processed for qRT-PCR analysis of lip3. Lip3 transcription was 
strongly repressed upon expression of WT-HA (UAS-Schlank-HA, CT-HA tag) or HA-WT 
(UAS-HA-Schlank, NT-HA tag), and H215D-myc (UAS-SchlankH215D-myc, CT-myc tag). 
On the contrary, confirming the in vitro experiments, HA-NLS2 (UAS-HA-SchlankNLS2) 
did not repress lip3 expression (Figure 2.13, A). 
CerS2 variants were also tested in vivo. HA-CerS2, CerS2-H215D-HA, and CerS2-
NLS2-HA variants were expressed in the fat body of KINLS2 mutants. Transcription of lip3 
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was repressed upon expression of HA-CerS2 or CerS2-H215D-HA in KINLS2 mutants while 
CerS2-NLS2-HA did not repress lip3 expression (Figure 2.13, B).  
 
 
 
Figure 2.13. Lip3 transcriptional regulation in vivo. A) Transcript levels of Iip3 in L3 KINLS2 mutant larvae 
upon expression of HA-WT or WT-HA, H215D-myc, or of a Schlank NLS2 variant (NLS2-HA) under control 
of the cgGal4 driver line. B) Transcript levels of lip3 in KINLS2 mutant larvae upon expression of CerS2-HA, 
CerS2-H215D-HA or CerS2-NLS2-HA using the cgGal4 driver line. KINLS2 larvae carrying the cgGal4 driver 
line but not expressing Schlank variants were used as a control. Transcript levels were determined using qRT-
PCR (n = 3) and normalized on rp-49 expression. Error bars indicate SEM, *** p<0.05, ** p<0.01, *p<0.001. 
 
These data provide substantial evidence that Schlank controls lipid metabolism by 
regulating transcription via the homeodomain and that the catalytic activity is not required 
for this function. Furthermore, this function seems to be conserved in the mammalian CerS2.  
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2.4 The physiological role of Schlank in the regulation of lipases  
2.4.1 Schlank DNA binding and nuclear localization depend on nutrient availability 
 
The previous data prove that Schlank can regulate transcription via DNA binding. 
However, how and when the regulation takes place in physiological conditions remains 
an open question. As mentioned earlier, lip3 is generally upregulated in starvation (Zinke 
et al., 2002) and it has been used for several years as a starvation marker. To understand 
whether the transcriptional regulation of Schlank on lip3 would be starvation-dependent, 
DNA binding during starvation was tested. To eventually determine DNA binding in 
starvation, S2 cells were firstly transfected with HA-WT Schlank variant. After 48h 
incubation with complete nutrient-rich medium to allow the cells to express the constructs 
efficiently, S2 cells were starved for 6h in serum-free media (FBS, fetal bovine serum) 
and subsequently processed for ChIP. As showed above, HA-ChIP from fed S2 cells 
resulted in enriched regulatory regions of lip3 and magro. 
In contrast, in the HA-ChIP from starved S2 cells, the investigated regulatory regions 
were no longer enriched (Figure 2.14, A). The same experimental set up was also used 
for luciferase reporter assay. Confirming what was observed by ChIPs, HA-WT was no 
longer able to suppress the luciferase activity when S2 cells were starved, similar to the 
results obtained when the NLS2 mutant variant was used for the reporter assay (Figure 
2.14, B and Figure 2.12, B, modified from Sociale et al., 2018). 
 
 
Figure 2.14. Schlank DNA binding in starvation. A) Quantification by qRT-PCR of ChIP material from S2 
cell extract transfected with HA-WT, which then were fed or starved for 6h, using a-HA antibody (n = 3). B) 
Relative luciferase induction upon expression of either HA-WT in fed and starved S2 cells (n = 3). Error bars 
indicate SEM. ** p<0.01, *p<0.05. 
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In the likely case that Schlank would act as a suppressor of lip3 and magro during feeding 
conditions, it would need to leave the enhancer regions of these two genes to allow the 
activation of gene expression by other factors, for instance under starvation. Thus, it was 
tested whether Schlank would change localization during starvation. After expression of HA-
WT, Schlank nuclear localization and specifically the ratio nucleus versus cytoplasmic 
Schlank was measured in S2 cells after 3, 6, and 12h of starvation. The quantification 
revealed a reduced Schlank nuclear localization upon starvation. To rule out that this 
observed strong effect was due to an artefact deriving from the expression of a tagged 
protein, the same experiment was conducted in non-transfected S2 cells and the localization 
of endogenous Schlank was determined. Also in this case, a significant reduction in nuclear 
localization was observed upon serum starvation (Figure 2.15, A, B, C, Sociale et al., 2018).  
 
 
Figure 2.15. Schlank nuclear localization upon serum depletion (starvation). A) Representative images of 
S2 upon serum deprivation stained with α-lam (green) and Schlank (magenta) and DAPI. B) Nuclear 
localization of HA-WT determined in S2 cells, C) and of endogenous Schlank nuclear localization upon 
starvation at different time points using α-HA and α-CT respectively. The ratio of colocalized Schlank and 
DAPI versus cytoplasmic Schlank was quantified and plotted as percentage of nuclear Schlank. Error bars 
indicate SEM. ***p<0.001, ** p<0.01, *p<0.05 
 
In this context, nuclear localization was also evaluated during in vivo larval starvation in 
fat body cells, confirming that nuclear Schlank diminished upon starvation. (Sociale et al., 
2018, Appendix Figure 5.4, A). 
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2.4.2 Lipid sensing and transcriptional regulation  
 
Metabolic regulation and physiological feedback systems are central to all aspects of 
postembryonic life in every organism, and at the cellular level, they need to adjust gene 
expression quickly.  
In the context of ceramide synthesis MCFA are needed in two steps of the pathway 
(Figure 1.1, A). Schlank links to sphinganine mainly C14-CoA-activated fatty acids for the 
production of ceramide (Bauer et al., 2009).  
Moreover, FBS (depleted in our starvation assay for S2 cells), besides containing 
nutrients and factors needed for the survival and cell propagation, is rich in lipid and fatty 
acids. Different sera contain distinct compositions of FAs (Lagarde et al., 1984). In 
established cell lines, different sera cause an alteration in FAs composition. Since serum 
deprivation associates with reduced Schlank nuclear localization, FAs of different chain 
length were tested in S2 cells to verify whether they would affect Schlank localization during 
serum starvation. FA-conjugated with bovine serum albumin (BSA), (either C12-BSA, or 
C14-BSA, or C16-BSA) were added to the medium. BSA alone was used as vehicle control. 
The experiments were performed on transfected HA-WT and endogenous Schlank. In 
both cases, with a minor but significant percentage for endogenous Schlank, supplementing 
FAs in a serum deprivation status shifted Schlank localization from the ER toward the INM 
supposing that Schlank might directly or indirectly sense the lipids and nutrient composition 
and shuttle between INM and ER (Figure 2.16, A, B, C). 
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Figure 2.16. Schlank nuclear localization upon FA administration. A) Representative images of S2 cells 
upon administration of several C-chain FA (C12, C14, C16), stained with α-lam (green) and Schlank (magenta) 
and DAPI (blue) upon serum deprivation (BSA control). B) Nuclear localization of HA-WT determined in S2 
cells, C) and of endogenous Schlank nuclear localization upon FA administration at different time points using 
α-HA and α-CT respectively. The ratio of colocalized Schlank and DAPI versus cytoplasmic Schlank was 
quantified and plotted as percentage of nuclear Schlank. Error bars indicate SEM. ***p<0.001. 
 
 
2.4.3 Fatty acid availability and adapted transcriptional response  
 
The nuclear localization experiments upon changing nutrient conditions have highlighted 
the fact that Schlank responds to FA and shifts subcellular localization. 
To assess whether the shift to nuclear localization upon FA feeding correlates directly 
with the transcriptional response operated by Schlank, an ex vivo assay was established in 
this thesis. Since lip3 is expressed mostly in the larval fat body while magro is a gastric 
lipase, fat body and gut were chosen for this assay. Fat body and gut of KIWT were exposed 
in a sugar-free Ringer´s solution, an isotonic solution that resembles the body fluids of the 
animal. Sugar (glucose or trehalose) was not used in the solution to mimic starvation and 
allow, in first instance, an upregulation of lip3 expression. To test the responsiveness to FA, 
different chain length FA-conjugated with BSA, (either C12-BSA, or C14-BSA, or C16-
BSA) were added to the solution. BSA alone was used as vehicle control.  
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On condition that FA are responsible for the signal to downregulate lipases, it should be 
possible to observe a downregulation of lip3 in comparison with BSA control.  
Indeed, there is a repression of lip3 and magro in KIWT fat body and gut when C12, 
C14, and C16 are supplemented with the solution (Figure 2.17, A). To rule out a possible 
and unspecific effect on transcriptional regulation caused by a gain of energy through 
increased β-oxidation upon fatty acid treatment, β-oxidation was blocked with an 
inhibitor of carnitine palmitoyltransferase (cpt1), commonly called Etomoxir keeping the 
same experimental setup. The treatment with the inhibitor did not affect the results 
(Figure 2.17, B, Sociale et al., 2018) meaning that Schlank is responsible for adapting 
transcriptional regulation according to fatty acid status. 
 
 
 
Figure 2.17. Ex vivo assay of dissected fat bodies and gut from KIWT. A) qRT-PCR on KIWT fat body/gut 
after 6h incubation with saturated fatty acids of different chain length (C12, C14, and C16) coupled to BSA. 
BSA only was used as a control. B) Same experimental setup with the addition of 200 µM of Etomoxir, used 
to block β-oxidation. Expression level normalized on rp-49. Error bars indicate SEM (n=3). ***p<0.001, ** 
p<0.01, *p<0.05 
 
 
 
Furthermore, to prove that this transcriptional response upon FAs administration is indeed 
operated by Schlank through DNA binding the same set of ex vivo experiments were 
performed for KINLS2 mutants. Because KINLS2 mutants are no longer able to regulate 
transcription, no changes in lip3 and magro expression was expected when FAs are 
supplemented. Indeed in samples obtained from KINLS2 animals, ex vivo fatty acid treatment 
did not lead to a suppression of lip3 and magro (Figure 2.18, A, B). 
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Figure 2.18. Ex vivo assay of dissected fat bodies and gut from KINLS2. A) qRT-PCR on KINLS2 fat 
body/gut after 6h incubation with saturated fatty acids of different chain length (C12, C14, and C16) coupled 
to BSA. BSA only was used as a control. B) Same experimental setup with the addition of Etomoxir used to 
block β-oxidation. Expression level normalized on rp-49. Error bars indicate SEM (n=3). 
 
2.4.4 Fatty acid availability and in vivo transcriptional response 
 
In previous studies, it was shown that supplementing lipid-rich foods during larvae 
feeding, can increase organismal fat content in Drosophila mutants associated with different 
metabolic phenotypes (Ruiz-Sanz et al., 2001). For example, a partial dietary rescue of the 
previously published SchlankG0061 mutant was obtained by supplementing soy lipids. In fact, 
a higher number of larvae survived to adulthood (Bauer et al., 2009). To test whether the 
administration of FA-rich food would also rescue the KINLS2 mutants, different oil-
supplemented-diets were administered to the mutants. L1 larvae were fed with soy oil, olive 
oil, coconut oil, and cacao butter added to the yeast. Even though it was not possible to 
observe a rescue in development, L3 larvae were processed to measure lip3 gene expression. 
None of the supplemented oil rescued the lip3 phenotype of KINLS2 mutants (Sinah Löbbert, 
Bachelor Thesis). 
In the hypomorphic SchlankG0061 animals the DNA binding site is not affected and 
theoretically could still mediate a transcriptional response, which is agreement with the 
observed rescue upon dietary supplementation (Bauer et al., 2009). The fact that 
supplemented oils did not rescue the lip3 phenotype of KINLS2 mutants supports the idea 
that adaption of transcriptional regulation according to fatty acids status requires Schlank 
DNA binding.  
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2.4.5 The role of the catalytic motif in lipid sensing and signal transduction 
 
The task of maintaining lipid homeostasis is achieved by proteins combining the ability 
of TFs and the sensing of the energy status either alone or in combination with other factors 
(Varga et al., 2011). TFs as SREBP (Rawson 2003), a membrane-bound TF, and PPAR 
(Peroxisome proliferator-activated receptors)(Varga et al., 2011), a member of the nuclear 
receptor hormone superfamily, regulate gene expression in response to changing lipid 
content. Schlank, as per the above-mentioned factors, possesses a lipid binding domain 
(TLC; Lag1p) that needs to recognize and bind sphinganine (or sphingosine from the salvage 
pathway) and FA-CoA to catalyze the reaction of N-acylation.  
Therefore, the catalytic motif of the enzyme would represent a good candidate for the 
FAs sensing, transducing the signal for shifting nuclear localization to the homeodomain. 
To test this hypothesis, the ex vivo fatty acid treatment was performed while inhibiting the 
catalytic activity of the protein.  
Fumonisin B1 is a commonly used inhibitor for ceramide synthase activity, blocking the 
reaction of N-acylation (Wang et al., 1991). Fumonisin B1 was tested in two different 
concentration for the ex vivo assay (Ikram Arahouan, Bachelor Thesis), particularly 50 µM 
and 100 µM. Although, on average, a loss in the regulation of the tested lipases could be 
observed (Figure 2.19, A, B), like the one occurred for KINLS2 (Figure 2.18, A, B), the data 
present high variability and low reproducibility. This might be due to the toxicity of the 
inhibitor in such a delicate experimental setup.  
Next, KIH215D animals with a mutation abolishing the catalytic activity (Figure 2.1, D) 
were used to investigate the role of the catalytic domain in lipid sensing. 
However, these animals die approximately at 48h as L1 larvae (Figure 2.3, A, B) when, 
the larval fat body is almost inexistent and lip3 gene expression is still low (Pistillo et al., 
1998). Thus upon removal of the cuticle and most organs, the rest of the animal was used in 
the ex vivo experiments followed by RNA extraction and qRT-PCR analysis. Under these 
conditions, lip3 expression was not regulated upon FA administration for either KIWT or 
KIH215D samples (Figure 2.19, C, D).  
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Figure 2.19. Ex vivo assay of dissected fat bodies and gut blocking catalytic activity. A) qRT-PCR on 
KIWT fat body/gut after 6h incubation with saturated fatty acids of different chain length (C12, C14, and C16) 
coupled to BSA with addition of an inhibitor of Ceramide synthase activity (Fumonisin B) in two different 
concentration 50µM (n=6) and B) 100 µM (n=4). Black dots indicate the value for each of the replicate. BSA 
only was used as a control. C) qRT-PCR on L1 KIWT (n=3) or D) qRT-PCR on L1 KIH215D (n=3). Expression 
level normalized on rp-49. Error bars indicate SEM. 
 
To overcome the problems caused by developmental delay and larval lethality of both 
KIH215D and KINLS2, as a side project, a strategy for conditional mutagenesis was 
established. Schlank WT genomic DNA (gDNA) was cloned either in combination with HA-
tagged gDNA carrying the H215D or the NLS2 mutation into a so-called Allele switch 
vector (described by Baena-Lopez et al., 2013). This vector carries attB sites, as used for the 
generation of the different KI lines (Figure 2.1, A-G), and two different multiple cloning 
sites (MCS) spaced out by FRT (Flippase Recombinase Target) sites. The FRT sites can be 
recognised by Flippase (Flp), allowing and initiating site-directed recombination between 
two FRT sites. Flp-mediated excision of the FRT cassette, provokes the excision of the 
Schlank WT and subsequently the expression of the HA-tagged mutant variant at specific 
times and places (scheme of the genomic locus of the Allele switchKIH215D line is shown in 
Figure 2.20, A, See Appendix Figure A5.5 for recombination scheme). The availability of 
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numerous tissue-specific Flp-lines, together with the possibility of studying the mutations in 
time and tissue-specific manner, makes these newly generated lines a tool of great value. 
Notably, switching from a WT to an H215D mutation during L2 would allow monitoring 
lip3 expression upon FA administration to understand the role of the catalytic domain in 
lipid sensing. 
To this end, the Allele SwitchKIH215D line was crossed with a CD2 heat shock-sensible Flp. 
Larvae (44-48h) were then heat shocked for 2h and allowed to develop until L3 (HA 
expression tested 48h after heat shock, Ikram Arahouan, Bachelor Thesis). Those samples 
were used for ex vivo FAs assay as previously described. The result shows a reduction in 
lip3 and magro expression after treatment of the, now, KIH215D animals upon WT Flp-out 
(Figure 2.20, B). These preliminary experiments might suggest that Schlank does not require 
an intact catalytic motif for transcriptional regulation upon fatty acids stimulation. 
 
 
 
Figure 2.20. Allele SwitchKIH215D and ex vivo assay. A) Schematic of Schlank locus after reintegration of Allele 
SwitchWT-KIH215D in magenta is highlighted the mutation in the second Schlank allele, in light green is highlighted 
the HA tag to follow the occurrence of the switch and the red arrow represent the pax- cherry gene expressed 
in larvae and adult for the genotype selection. B) qRT-PCR on switched (48h) KIH215D fat body/gut after 6h 
incubation with saturated fatty acids of different chain length (C12, C14, and C16) coupled to BSA. Expression 
level normalized on rp-49. Error bars indicate SEM (n=3). ***p<0.001, ** p<0.01, *p<0.05. 
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2.5 Interaction partner and lip3 regulation 
 
Homeodomain proteins all bind to a very similar set of “AT”-rich DNA-binding sites and 
can activate some target genes and repress others at the same time. This information raises 
the basic question of how the specificity is achieved and how they orchestrate the various 
transcriptional responses (Mann et al., 2009). Hox DNA-binding specificity is modified 
through interactions with other DNA-binding proteins for the formation of a heterogeneous 
protein-TF-cofactor complex (Mann, 1995; Mann and Affolter, 1998; Mann and Chan, 
1996). These enable Hox functional specificity in vivo at particular target sites. Although in 
vivo study of endogenous Hox target gene regulatory elements has provided insight into the 
roles of cofactors at specific targets, relatively few target sites have been studied, and there 
is no clear understanding of the role of cofactors in Hox specificity. Indeed at some 
regulatory elements, the cofactors appear to be required for specific functional activity, gene 
activation rather than repression, and not for DNA-binding specificity (Li et al., 2011; Beh 
et al., 2016). 
Interestingly for this thesis, it was noticed that several of the lipases deregulated in 
KINLS2 mutants, besides lip3, were described in the literature as Foxo indirect target genes. 
For instance, although being responsive to Foxo overexpression, magro regulatory region 
does not contain conserved consensus binding sites for Foxo (Karpac et al., 2009). Foxo 
proteins are a group of TFs belonging to the Forkhead family. This family is characterized 
by a conserved DNA-binding domain, and it is known to be the main downstream effector 
of the ILS. They are involved in metabolism, stress protection, cellular differentiation, cell-
cycle arrest and apoptosis (Greer and Brunet, 2008; Partridge and Brüning, 2008; Salih and 
Brunet, 2008). Foxo TFs, like Hox proteins, have a similar, if not identical, DNA-binding 
domain. Direct interaction of Foxo proteins with diverse TF families can mediate the 
regulation of a plethora of cellular processes independently of Foxo DNA-binding, in a cell 
type-specific way (van der Vos and Coffer, 2008). Noteworthy, Foxo proteins have been 
shown to interact with multiple members of the nuclear hormone receptor (NHR) family 
leading to changes in the transcriptional activity of both proteins.  
For those reasons, it was tested whether Foxo could also regulate lip3 expression. Firstly, 
lip3 expression was measured in FoxoΔ94 mutants (Slack et al., 2011), which are 
characterized by a slight developmental delay, but survive until adulthood. At around 90h 
AEL, Foxo mutants were starved for 6h, and lip3 gene expression was measured by qRT-
PCR (Figure 2.21, A). Notably, lip3 is no longer upregulated upon starvation suggesting that 
lip3 might also be a Foxo target. In addition, Foxo-GFP (Foxo) overexpression and FoxoRNAi 
 37 
were tested on lip3 luciferase reporter in S2 cells. Strikingly, Foxo overexpression 
suppressed lip3 luciferase activity, and FoxoRNAi caused an increase in luciferase activity 
(Figure 2.21, B) as observed for Schlank overexpression and RNAi (Figure 2.12, A). To 
assess whether and how Foxo and Schlank might regulate transcription of lip3 together, 
different combinations of coexpressed vectors were tested.  
The rationale of this experiment follow the assumption that if Schlank and Foxo need 
each other to modulate lip3 activity in the absence of one or the other, lip3 luciferase 
suppression should not be observed. Schlank was overexpressed together with FoxoRNAi and 
vice versa, and lip3 activity monitored. In both combinations, it was no longer possible to 
suppress lip3 activity (Figure 2.21, C). When Foxo was overexpressed together with Schlank 
(WT-HA), there was a normal suppression of the luciferase reporter. However, when the 
NLS2 variant was overexpressed with Foxo, the regulation was abolished (Figure 2.21, D). 
Thus, Schlank and the DNA binding capacity of Schlank appears to be required to mediate 
the repressive effect of Foxo on lip3 regulation in S2 cells and more generally Foxo and 
Schlank might work together to modulate lip3 gene expression (Figure 2.21, C, D). 
 
Figure 2.21. Foxo and lip3 
regulation. A) Lip3 expression 
levels in starved (L3 90h to 96h) 
KIWT larvae and Foxo mutant 
larvae that fails to upregulate lip3 
upon starvation. Samples 
normalized on the lip3 expression 
of non-starved KIWT (dotted line). 
Transcript levels of lip3 quantified 
using qRT-PCR (normalized to 
rp-49). B) Relative luciferase 
induction upon expression of 
neGFP, Foxo-GFP (Foxo) and 
FoxoRNAi, C) KD of Foxo while 
overexpressing Schlank and KD 
of Schlank (WT-HA) while 
overexpressing Foxo abolished 
repression on lip3 reporter. D) and 
co-expression of HA-WT or NLS2 with Foxo have opposite effect on lip3 reporter activity. Error bars indicate 
SEM (n=3). ***p< 0.001, ** p<0.01, *p<0.05. 
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To verify whether they might interact directly or indirectly, coimmunoprecipitation 
(coIP) experiments were carried out. HA-tagged Schlank and GFP-tagged Foxo were 
transfected and expressed in S2 cells. Using the respective antibody, each of them was 
separately precipitated from extracts of S2 transfected cells. GFP-Foxo was able to coIP HA-
Schlank and vice versa (Figure 2.22, A). To confirm that the NLS2 would affect the DNA 
binding rather than the stability of the protein and consequently the interaction between 
Schlank and Foxo, a coIP experiment was performed on extracts containing the coexpressed 
Foxo-GFP and NLS2-HA fusion proteins. The interaction was not affected and maintained 
despite the mutation. 
Essential to understanding this possible synergistic interaction between Schlank and Foxo 
is the evidence that, opposite to Schlank, Foxo is shuttling from the cytoplasm to the nucleus 
upon starvation, representing a controversy for this interaction. It is also true that the 
localization of both, Schlank or Foxo is never exclusively ER/Cytoplasmic or INM/Nuclear. 
To gain more information about the lip3 regulation by Foxo in starvation more luciferase 
assays were performed. In starvation, the overexpression of Foxo increased the luciferase 
activity, while FoxoRNAi no longer increased luciferase activity (2.22, B).  
 
 
 
Figure 2.22. Schlank-Foxo interaction and lip3 regulation upon starvation. A) CoIP of HA-tagged Schlank 
with GFP-tagged Foxo and vice versa. S2 cells were either transfected with expression plasmids for both, HA-
tagged Schlank (~47 KD) and GFP-tagged Foxo (~110 KD) or with HA-tagged Schlank or GFP-tagged Foxo 
only, which were used as negative controls. No unspecific CoIP signal was detected using protein extract of 
S2 cells. Immunoblot was performed alternatively with α-HA or α-GFP antibodies. B) Foxo and lip3 regulation 
upon starvation. Relative luciferase induction upon expression of Foxo-GFP (Foxo) and FoxoRNAi (6h), lip3 
gets enhanced by FoxoRNAi in a fed status (as in Figure 2.21B), while the suppression of Foxo (FoxoRNAi) during 
starvation does not upregulate lip3 expression. Foxo is needed during starvation to upregulate lip3 expression. 
Reporter activity normalized to Renilla luciferase control transfection (n= 3).Error bars indicate SEM. *p < 
0.05, **p<0.01. 
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These results represent a proof that in starvation, Foxo is needed for the overexpression 
of lip3. Because of the non-exclusivity of the localization and the need of cells to quickly 
regulate transcription, Schlank and Foxo might always be present in more or less amount 
on the enhancer of lip3 depending on the feeding status. During starvation, Schlank 
nuclear localization diminishes, while Foxo nuclear localization increases and perhaps 
through the modulation of the complex by cofactors or other TFs, lip3 expression might 
be enhanced.  
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3 Discussion  
 
Regulation of lipid homeostasis and maintenance of stable cellular lipids patterns on 
individual cell surfaces and within different compartments of the cells requires precise 
control of lipid biosynthesis, degradation, and intracellular transport. During the past years, 
more and more pathologies and pathophysiological processes have been associated with 
disruption of lipid homeostasis. These processes are not only related to energy consumption 
but numerous signalling events. How eukaryotic cells sense and control their lipid 
composition remains an open question for several classes of lipids. For those reasons, it is 
necessary to understand how metabolic enzymes are regulated, identify the dedicate lipid 
sensors, and track down the regulatory machinery of the signalling cascade.  
 
3.1 CerSs and transcriptional regulation 
 
The findings that the nuclear pool of Schlank at the INM plays a role in the regulation of 
body fat homeostasis has opened up an unexplored and appealing field of research.  
Schlank localizes at ER and the INM. Ketel, the homologous of Importin β in Drosophila, 
is involved in Schlank nuclear import, recognizing NLSs within the homeodomain. Notably, 
Schlank was never found floating in the nucleus, but the presence of an inner ring 
circumscribed by lamin staining is particularly visible in fat body cells (Voelzmann et al., 
2016; Sociale et al., 2018, Appendix Figure 5.2, B). The TM-free homeodomain failed to 
rescue the previously described Schlank P-element mutants (Appendix Figure 5.4, B; Sociale 
et al., 2018), meaning that the protein needs to be anchored to the membrane to accomplish 
its nuclear function. Analysis of in vivo models carrying different mutations within the 
homeodomain, generated via homologous recombination (Figure 2.1, A; G), clearly showed 
that at least one of the mutation correlates with an altered nuclear function (Figure 2.3; 2.4). 
Essentially, the NLS2 mutation is associated with deregulated transcription of lipase 
expression, and with a number of deregulated genes involved in several other cellular 
processes appearing in the RNA sequencing analysis output (Figure 2.5; 2.9). 
In the last years, numerous screenings in mammalian CerSs KO models have shown that 
ceramide imbalance is associated with deregulated gene expression (Pewzner-Jung et al., 
2010; Bickert et al., 2018). The novelty about the screening described here resides in the fact 
that the altered gene expression regulation in the KINLS2 mutant is not due to a loss of 
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catalytic activity of the protein (Figure 2.7, A), or to a loss of interaction with other proteins 
but it is exclusively related to the homeodomain function, as the protein expression and its 
enzymatic function were unaltered. These findings prompt a more accurate investigation into 
the nuclear function of Schlank and the possibility that Schlank might regulate transcription 
via DNA binding.  
 
3.1.1 CerSs as DNA binding proteins: transcription factor or chromatin 
remodeller?  
 
Some INM and ER connected-ONM proteins interact in the nuclear lumen to take part in 
chromatin regulation. Proteins that are integral to the INM are generally linked to 
transcriptional silencing. Meanwhile, proteins whose localization is regulated by nuclear 
pore complexes or their components have been linked to both transcriptionally inactive and 
active loci in different organisms (Mekhail et al., 2010). 
The NLS2 site is located in the third helix of the homeodomain. This portion of the 
homeodomain is known to be essential for establishing the first contact with the DNA. 
Different classes of homeodomains show in general high variability (Noyes et al., 2016). 
Amino acids considered essential for the function are substituted with others of similar 
properties, and only a few residues are highly conserved and remain invariant in each class. 
The NLS2 mutation affects one of these critical residues, an Arginine (R) in position 50 
(RLRR to ALAR), described to be crucial for DNA binding (Bürglin and Affolter, 2015).  
By performing ChIP experiments, it was possible to show that Schlank can bind DNA 
specifically to regulatory regions of genes that were deregulated (lip3 and magro) (Figure 
2.11, B) in the KINLS2 mutant. The NLS2 mutation specifically abolished the DNA binding, 
while the mutation in the catalytic motif (H215D) and other mutations within the 
homeodomain (NLS1, E118A) (Figure 2.11, C, D) did not affect the binding. The fact that 
the NLS1 and E118A mutations within the homeodomain did not alter DNA binding and 
gene expression, even though ceramide synthesis was affected for KINLS1 mutants (Figure 
2.7, A) was not expected.  
Moreover, it was shown by luciferase assay, that the NLS2 site is indeed responsible for 
the regulation of lip3 (Figure 2.12 A, B) in vitro. This confirms lip3 as a direct Schlank target 
gene. Rescue experiments in the background of the KINLS2 mutant further strengthen the 
results on lip3 transcriptional regulation operated by Schlank in vivo (Figure 2.13, A).  
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Besides lip3, it would be fair to assume that the altered gene expression of some of the 
enzymes of the sphingolipid pathway is the result of the loss of the DNA binding (Appendix 
Figure A5.3, C). However, whether the several deregulated genes appearing in the RNA-seq 
(Figure 2.9, A, B, C) are indeed Schlank target genes is to date hard to define. It was not 
possible to prove this during this work, even though different approaches were used.  
The first approach used was the scan of the promoter/enhancer regions of genes whose 
expression resulted deregulated in the RNA-seq for Schlank binding motif. This analysis 
was not possible due to the observation that the putative and variable Schlank binding 
consensus is spread all over the genome and not directly associated to promoter/enhancer 
regions. This generally occurs for most of the other Hox-domain-transcription factors. ChIP-
seq of ChIPs samples from S2 cells on endogenous Schlank was performed in a second 
attempt. Even though the ChIP showed a positive output by qRT-PCR, the sequencing 
resulted in several genome-spread picks. Poor quality libraries resulted from the sequencing 
approach used. The reasons behind this are not yet clear and more tests are needed to figure 
out which parameters have to be changed. 
The observation of the “randomly-scattered” Schlank consensus binding sites, however, 
is actually in agreement with several publications on Hox-domain and chromatin 
remodelling. Genome-wide occupancy data reveal a wide discrepancy between predicted 
and observed binding of TFs. The vast majority of consensus motifs found in the genome 
are not bound by the respective TF (Wang et al., 2012). The presence of a binding motif per 
se is not sufficient for directing TFs to their target sites in the genome. The interaction TF-
DNA in vivo is also determined by chromatin landscape, nucleosomes conformation, and 
from the presence of the DNA binding consensus in the minor or mayor grove of the DNA. 
While TFs appear to preferentially bind to regions of open and accessible chromatin (Kaplan 
et al., 2012; Kaplan et al., 2011), pioneer TFs often identified as homeodomain proteins, can 
interact with several other components and actively open condensed chromatin (Zaret and 
Mango, 2016). Control of gene expression by homeodomain proteins indeed relies on 
interaction with chromatin remodelling complexes, specific histone modification, various 
types of DNA-binding proteins and tissue-specific TFs, non-coding RNAs and cofactors 
(Bobola et al., 2017). Experimental evidence for these plausible properties for Schlank 
comes from a yeast 2-Hybrid screening previously performed. The results showed a strong 
interaction with a Chromatin-Decondensation factor 31 (Df31) (Reinhard Bauer personal 
communication). To study more in detail these proposed mechanisms for how Schlank exerts 
its function some ambitious and challenging experiments might be performed in the future. 
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The newly generated AlleleSwitchKIWT-KINLS2HA and the AlleleSwitchKIWT-KIWTHA lines 
(Appendix Figure A5.5) might be used to establish an in vivo ChIP protocol. The benefits of 
using this set of experiments to solve the previously described problems of the ChIP-seq 
would be multiple. S2 cells are embryonic derived cells that tend to differentiate after few 
passages in cell culture and/or different conditions (as shown in Appendix Figure A5.8 for 
the overexpression of elovl-4, unrelated to this project). The possibility of switching time 
and tissue specifically (overcoming the problems related with protein overexpression) to the 
tagged Schlank variant would allow to immunoprecipitate the HA-Schlank in a precise organ 
or subset of cells, with no need for organ dissection or cell-sorting. Moreover, the possibility 
to compare the latter with NLS2-HA ChIP would represent a standardized (α-HA IP) “yes 
or no” set of experiments that would be much easier to analyse for ChIP-seq. It would be 
exciting, also, to combine these experiments with studies of chromatin accessibility. For 
instance, ATAC- or FAIRE-seq might be performed. These experiments, together with the 
previously described HA-ChIP-seq would allow to verify the status of the chromatin when 
Schlank is bound (HA-WT) or not bound (NLS2-WT). 
 
3.1.2 The function of the NLS2 site in vertebrates  
 
In this thesis, it was also possible to show that mutation of the NLS2 like motif in the 
murine CerS2 led to a loss of transcriptional control on lip3 luciferase activity in vitro 
(Figure 2.12, C) independently of the catalytic activity (H215D). Moreover, by rescues 
experiments was possible to demonstrate this regulation on lip3 also in vivo (Figure 2.13, 
B), indicating that the NLS2 motif might play a similar role in mammals. 
Five out of six CerSs in mammals have a homeodomain, and all except CerS3 have an 
NLS2 like motif (Appendix Figure 5.7, A). More experiments are needed to prove the 
effective CerS DNA binding capabilities in a mammalian system. ChIPs and luciferase 
assays should be established in a mammalian cell line in order to affirm that mammalian 
CerS is binding DNA. For instance, CerS6 was shown to transcriptionally activate Acid 
Ceramidase (ASAH1) in different mammalian cell lines (Tirodkar et al., 2015), representing 
a good target for luciferase experiments. A very recent publication confirmed some of the 
data of this thesis work in Danio Rerio (Mendelson et al., 2017). CerS2b protein is activating 
its expression, and while the mutation in the equivalent NLS2 site (RRRR-WSRR) abolished 
the regulation, the mutation in the catalytic motif did not. This confirms the conserved 
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function of the NLS2 site in another model organism. This experimental evidence is 
promising for a transcriptional regulation homeodomain-dependent for mammalian CerS.  
 
3.2 Possible mechanisms of transcriptional regulation via Foxo-interaction 
 
The remodelling activities described for several homeodomain proteins underlie their 
ability in promoting reprogramming activities, binding on closed chromatin facilitating the 
binding of secondary factors (of site-specific TFs and co-activators) and assembly of active 
transcriptional complexes for local gene expression. In fact, it has been suggested that Hox 
proteins do not activate gene expression themselves, but act as transcriptional ‘guarantors’ 
to promote activation of target genes regulated by other TFs (Zheng et al., 2015), adding or 
altering the specificity of the Hox-protein. 
Foxo was chosen as a possible interaction partner for Schlank. This is because some of 
the lipases found deregulated in KINLS2 were described in the literature as indirect Foxo 
targets. Moreover, it has already been shown that the association of Foxo with several other 
TFs either inhibit or enhance their transcriptional activity (Li et al., 2001, Li et al., 2003, Fan 
et al., 2007).  
In this thesis, it was possible to show by luciferase assay experiments that Foxo can 
regulate lip3 when its activity was modulated alone, or in combination with Schlank (Figure 
2.21, A; C). Despite the fact that ILS and Foxo activity were not affected in the KINLS2 
mutants (Figure 2.5, C, E), a motif enrichment analysis for Foxo among the 20 mostly up 
and down-regulated genes from the RNA-seq, resulted in three differentially regulated Foxo 
target genes (LyseD, LyseE, and Frq1, highlighted in bold in Figure 2.9, B). Supporting and 
expanding the potential regulatory interaction between Schlank and Foxo. 
Interaction of Foxo proteins with diverse TF families or cofactors can lead to altered 
transcriptional responses through a variety of mechanisms. Foxo-binding elements are found 
adjoining or overlapping with other TFs, or far away from the enhancer/promoter regions. 
The examples are numerous where enhancer regions are located far in the genome even on 
different chromosomes and still are necessary for the transcriptional regulation (Kulaevaa et 
al., 2012). Foxo might for example bind to its binding motif in a region that is not associated 
with lip3 regulatory region, and because of the nuclear positioning of the DNA, still being 
in close proximity and able to physically interact with Schlank. This could result in an 
enhanced transcriptional response or repression as for Schlank and lip3 (Figure 2.12; 2.21). 
Moreover, the association between Foxo and other proteins can often recruit additional 
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factors. The recruitment of histone acetylase transferases (HATs) or histone deacetylases 
(HDACs) to promoters, and the association with diverse TFs can, for example, lead to 
activation or suppression of transcription. Foxo-TFs association can also result in an altered 
cofactor distribution to target promoters. When one of the components in a complex is a 
limiting factor and also binds Foxo, it may result in inhibition of transcription or may even 
lead to increased proteolytic degradation of Foxo or Foxo-associated TFs. 
In most cases, phosphorylation of Foxo leads to a disruption of the complex. Interestingly, 
Foxo has been shown to interact with several NHR independently of the presence of the 
NHR ligand, as for instance the PPAR- α and γ, the hepatic nuclear factor-4 (HNF4) in 
mammals. They are also involved in metabolic processes underlining the importance and the 
interconnection of lipid metabolism and insulin signalling (van der Vos and Coffer, 2008). 
Although the experiments in this thesis have provided evidence for a possible interaction 
between Schlank and Foxo, and for a possible regulatory mechanism of lip3 gene expression, 
the molecular mechanisms and the biological and physiological relevance of this interaction 
genome-wide are still elusive. 
More experiments are needed to better understand the modulation of lip3 expression. 
Several coIP experiments should be performed. For instance, coIPs could be performed 
during starvation to monitor perhaps a reduction or a loss of interaction.  
To understand which portion of Schlank is responsible for the interaction it could be 
possible to overexpress ad coIP the several available, truncated, and mutated Schlank 
variants (Anna-Lena Wulf, PhD thesis; André Voelzmann, PhD Thesis). In fact, by 
bioinformatics tools (DisEMBL, Appendix Figure A5.6, A, Linding, et al., 2013) it was 
possible to identify within the Schlank C-Terminal portion a low complexity region, known 
from literature to mediate and facilitate protein-protein interactions (Dyson and Wright, 
2005; Pancsa and Fuxreiter, 2012). 
The interaction between these two key and regulatory proteins in vivo also needs to be 
carried on in the future. The double mutant KINLS2-FoxoΔ94 resulted in being larval lethal 
as well as foxo knock down (UAS-FoxoRNAi) in the background KINLS2 mutants (Sinah 
Löbbert, Bachelor Thesis). New insights might be acquired by playing with the expression 
of these two factors in clonal analysis. Using the newly generated Schlank-allele switch lines 
would overcome the lethality of the double mutants and lip3 activity could be monitored in 
different tissues and developmental stages.  
The importance of this interaction is reflected in a number of previous publications 
that although not investigating the homeodomain function, established a link between the 
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activities of CerSs 2, 5, and 6 and the level of C16-Cer with obesity and insulin resistance 
(Reali et al., 2017; Turpin et al., 2014; Gosejacob et al., 2016). The data described above 
might represent the first connection between ILS and CerSs.  
 
3.3 Schlank function in fat metabolism regulation and lipid homeostasis  
 
This thesis demonstrates that Schlank binds DNA via the homeodomain and that the 
NLS2 site is necessary for the binding (Figure 2.11; 2.12). Schlank´s role in adapting 
transcriptional response depending on the energy status, is reflected by the fact that Schlank 
DNA binding, as well as nuclear localization, shift during fed and starved status (Figure 
2.14; 2.15). Moreover, it was shown that FA are targeting Schlank to the nucleus and they 
represent the signal to repress lip3 expression (Figure 2.16; 2.17). 
This mechanistic model is consistent with the phenotypes observed in KINLS2 mutants 
highlighting that Schlank transcriptional regulation is needed to maintain lipid homeostasis. 
The mutant phenotypes associated with lack of transcriptional regulation that affects storage 
of TAG, FA synthesis (Figure 2.4; 2.6), and, generally, lipolytic and lipogenic processes 
(Figure 2.5, 2.9), beside sphingolipid biosynthesis (Appendix Figure A5.3, A).  
This thesis aimed at understanding the role of Schlank nuclear function in regulating fat 
metabolism. As mentioned in the introductory paragraph describing the fate of fat, the 
quantity and quality of dietary lipids are known to have an impact on the composition of 
tissue lipids in Drosophila (Jones et al., 1992) and mammals (Aoun et al., 2012, Field et al., 
1984). Nevertheless, the composition of intracellular TAG stores also depends on the action 
of other enzymatic systems and reflects the activities of enzymes responsible for 
synthesizing, desaturating and elongating FFAs (Papackova and Cahova, 2015).  
TAGs stored in the form of cytoplasmic lipid droplets are not only passive energy depots. 
Their degradation forms pleiotropic bioactive intermediates, which contribute to the 
regulation of several cellular processes functioning as cofactors for transcription factors or 
enzymes. 
Lipases are the enzymes responsible for intracellular TAG hydrolysis, so they not only 
ensure energy substrate release but actively regulate energy metabolism of the cell. From the 
hydrolysis of TAGs originate FFAs. FFAs may be generated de novo, imported from the 
plasma pool or generated by lipoprotein lipases and then transported into the cell. FFAs are 
not mobilized in direct proportion to their content in TAG but selectively according to their 
molecular structure. FAs are essential substrates for oxidation and production of cellular 
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energy as well as precursor molecules for all lipid classes. They act as powerful signalling 
molecules, which regulate numerous cellular processes associated with lipid metabolism and 
which ensure precise FFA release and demand. FFAs and their derivatives may regulate 
intracellular processes at several levels as gene transcription activation, post-transcriptional 
modification of proteins (for instance acylation) and direct modulation of enzyme activities 
as co-activators (Raclot et al., 1999). Thus FFAs can become harmful to cells also if present 
at low concentrations and must be released under tight metabolic control. Depending on their 
structure, FFAs can initiate diverse signalling independently or dependently of gene 
transcription modulation. The indirect effects of FFAs derive from many mechanisms. These 
effects are mostly due to changes in fatty acyl composition of membrane lipids which 
determine membrane fluidity, lipid raft structures and, as a consequence, signal transduction 
(Vessby et al., 2002, Jump et al., 2002).  
To regulate cellular metabolism transcriptionally, FAs act as agonistic ligands of different 
nuclear receptors. When activated, these factors bind to the promoter regions of specific 
genes and selectively affect their transcription. FFA-binding nuclear transcription factors 
belong to several families, including PPAR, and SREBP. Short chain fatty acids (SFA), for 
instance, stimulate the expression of genes involved in the SREBP pathway and cholesterol 
homeostasis (Jackson et al., 2006; Lin et al., 2005, Jump et al., 2005). Poly-unsaturated fatty 
acids (PUFA), potently suppress genes involved in de novo lipogenesis (Xu et al., 1999), 
FFA desaturation (Worgall et al., 1998) and elongation (Jump et al., 2005) via SREBP.  
All of these distinct pools may serve as a source for signalling molecules, which differ 
concerning to tissue, metabolic stimuli, and lipase-derivation. Whether these FAs directly 
serve as nuclear receptor ligands, or if they need to undergo an esterification/hydrolysis cycle 
first is not yet known (Papackova and Cahova, 2015). 
Additionally, more than one step of sphingolipid de novo biosynthesis depends on the 
availability of FA-CoA (Figure 1.1, A). In the first rate-limiting step of the pathway, FA-
CoA is required to generate the substrate of ceramide, sphinganine and secondly it is required 
for acylation of the sphinganine to produce ceramide. Thus, the supply of FAs should be 
expected to play a key role in the determination of the rate of ceramide synthesis and quantity 
of ceramide generated by the de novo synthesis pathway.  
Lip3 is responsible for the accumulation of FFAs (Bülow et al., 2017). During starvation 
Schlank does not bind to DNA, changes subcellular localization (between INM and ER), 
releasing lip3 enhancer (Figure 2.14; 2.15) which gets activated. In animals, during 
starvation conditions FAs are mostly used to gain energy through β-oxidation correlating 
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with reduced FAs available for ceramide synthesis. During development and particularly 
during the latest larval stages, ceramides and in general sphingolipids are necessary for 
proceeding to pupariation. Under this condition, by increasing the ER localization, Schlank 
could be waiting to be triggered by a signal, and ready to welcome sphinganine and FA-CoA 
for the production of ceramides.  
Furthermore, it was not only possible to show that in a FA-overloaded condition, Schlank 
is shuttling from the ER to the nucleus but also that FAs are the signal for the repression of 
lipases during starvation (nuclear localization and ex vivo experiments, Figures 2.15, 2.16, 
2.17, 2.18). Regrettably, for the methods used in thesis, it was not possible to univocally 
prove that Schlank senses the lipid status of the cell directly or, more specifically, that the 
binding of the FAs to the catalytic domain triggers the shift in localization and lipases 
repression (Figure 2.19).  
The ex vivo experiments of samples of the AllSwitchKIH215DHA line (Figure 2.20, B) are 
only preliminary data. The perfect genetic control (AllSwitchKIWTHA) that would allow the 
switch from a WT to a WT-HA Schlank variant is missing in this experimental setup. Due 
to difficulties in cloning two identical and perfectly matching sequences in the same 
construct (WT; WTHA), this fly line has not yet been generated.  
The percentage of cells “switching” from WT to H215D was not tested previously to 
performing this experiment. For this reason, these experiments need to be repeated, and in 
parallel, the Flp efficiency needs to be monitored by antibody stainings. 
Moreover, further experiments are needed to prove the non-involvement of the catalytic 
domain in lipid sensing and signal transduction. In a recent publication, it was shown that 
the acyl chain specificity of CerSs is connected to a stretch of amino acids residing between 
the last two transmembrane domains (6th and 7th) (Tidhar et al., 2018). 
Although it is not known, how the protein is folded, which shape the enzymatic pocket 
assumes, and where exactly sphingosine and FA-CoA are binding, it is possible that with the 
experiments described here (Figure 2.19; 2.20), the side of the catalytic pocket deputised to 
the binding of sphinganine has been blocked. Fumonisin B1 has a high structural similarity 
to sphinganine, supposing that it binds to the same portion of the protein that the latter would 
be binding. Furthermore, the HH motif (important for catalytic activity and mutated in 
KIH215D, Figure 2.1, D; 2.2, A) is located within the Lag1p motif, between the 4th and the 
5th transmembrane domain, again not overlapping with the area described for acyl chain 
specificity between the 6th and 7th transmembrane domain (scheme for FA and sphingosine 
binding, Figure 3.1, A). In summary, it is highly probable that FA are still binding to the 
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protein after inhibition with Fumonisin and despite the mutation in the HH conserved 
domain.  
It is known that FAs can act as cofactors. Suppose that the binding of FAs would be 
indeed the signal that Schlank needs to shuttle to the nucleus to regulate transcription, this 
would still be possible in the above described experimental setup. 
 
Figure 3.1. Scheme for 
FA and Sphinganine 
binding to Schlank. 
Schematic of Schlank 
protein and where FA and 
Sphinganine might bind. 
The green star indicates 
the mutation in HD, while 
the orange polygon indicates the position of the aa responsible for acyl-chain specificity. In yellow is indicated 
sphinganine, in orange the FA activated with CoA (green square). 
 
In a possible mechanistic scenario, the over-binding of FA to the catalytic domain in the 
absence of sphinganine might act as a signal for nuclear translocation communicating that 
there are enough FAs available to be utilized as energy supply and for ceramide synthesis. 
Moreover, the binding of the FA as a ligand could also act as a cofactor inducing 
conformational changes leading to dimerization or recruitment of corepressor complexes.  
Interestingly, it was recently published that Ceramide synthase 2b mediates genomic 
sensing and regulation of sphingosine levels during Zebrafish embryogenesis. Mutations in 
the NLS2 site (RRRR-WSRR) of the Zebrafish CerS2b, similar to the NLS2 mutations 
described here, abolished the ability to respond to changing sphingosine (Mendelson et al., 
2017). In this work, CerS2b would shuttle to the nucleus and upregulate its own expression 
upon sphingosine treatment.  
The possibility that Schlank as CerS2b might be able to sense sphingosine levels is quite 
intriguing, and it would be easy to prove with the different methods established in this thesis. 
Ex vivo experiments might be performed with the addition of sphingosine or by blocking 
sphingosine generation. Moreover, it would also be possible to block the sphingolipid 
biosynthetic pathway at different levels upstream of Schlank. By blocking the first step of 
the pathway with an inhibitor of Spt and by blocking the synthesis of sphinganine, it would 
be possible to verify whether sphinganine is needed to convey the message for regulating 
transcription, or to better understand at which level of the pathway FAs are acting.  
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Alternatively, other proteins might sense FAs availability initiating a signal cascade, 
which then would cause the shuttling of Schlank. It is known that for instance that NLSs are 
usually revealed or masked by phosphorylation. Bioinformatics analysis for prediction of 
phosphorylation sites on Schlank resulted in the highest score for a Threonine (T) adjacent 
to the first part of the bipartite NLS2 site (Appendix Figure A5.6, B, B´). Studies of this T 
by mutagenesis, cell culture experiments and fly line generation might be carried out, to 
verify whether this amino acid is phosphorylated and if it is necessary for nuclear 
localization. 
In Summary, this work helped to unravel how Schlank regulates TAG, FA and lipase 
expression showing that the transcriptional regulation, exerted by DNA binding through the 
homeodomain, is dependent on the availability of FAs. 
Moreover, based on this work and particularly on the findings that Schlank shuttles to the 
nucleus and regulates transcription in the presence of FA, it was possible to demonstrate that 
in a model of peroxisomal biogenesis disorders (PDBs), Schlank is mislocalized. This causes 
an upregulation of lip3 and FFA-induced lipotoxicity. Moreover, MCFA (C12, and C14) 
administered via feeding of Coconut Oil, could rescue and stabilize most of the pathologic 
phenotypes by targeting Schlank to the nucleus, thus downregulating lip3 expression (Sellin 
et al., 2018). PBDs are rare genetic diseases caused by mutations in one of the approximately 
16 peroxin (PEX) genes, which are involved in the assembly and maintenance of 
peroxisomes. Patients with PBDs of the Zellweger syndrome spectrum have severe 
pathologic symptoms and usually, die during their first five years of life. Thus, the shuttle 
mechanism of Schlank upon FA described here has profound pathophysiological relevance.  
3.4 CerSs and pathophysiological processes  
 
Numerous studies with mouse KO models linked CerSs (2, 5, 6) function with lipid 
metabolism, obesity, diabetes and insulin resistance (Pewzner-Jung et al., 2010, Park et al., 
2013, Park et al., 2014, Raichur et al., 2014). For some of the mammalians KO, particularly 
for CerS2, it was possible to observe different phenotypes with different grades of severity 
even in heterozygosis. Meanwhile, CerS5 and Cers6 KO mice did not reveal a phenotype 
under normal conditions but instead, upon high-fat diet, these mice were protected from diet-
induced obesity (Turpin et al., 2014; Gosejacob et al., 2016). As KINLS1 and KIE118A 
mutants did not show an obvious phenotype (Figure 2.3; 2.4; 2.5), like CerS5 and CerS6, it 
might be interesting to challenge these homeodomain mutants with different diets. KIE118A 
is a model to study the SNP found by The Meta-Analyses of Glucose and Insulin-related 
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traits Consortium (MAGIC), associated with altered parameters for metabolic dysfunction 
and markers of diabetic kidney disease. It is not yet known whether the catalytic activity in 
KIE118A mutants is affected. However, KINLS1 mutants have a reduced catalytic activity 
(Figure 2.7, A), and, even though, transcriptional regulation of tested genes under normal 
conditions is not altered in these mutants. High sugar and lipid-rich food might be 
administered to these mutants. These experiments, together with luciferase assays in 
different culture media, might give more information about the importance of the mutations. 
The pathologies of the mammalian KOs were mostly attributed to ceramide imbalance and 
alteration in chain length specificity functions. Also in Drosophila, ceramide metabolism 
and accumulation were suggested as causal factors in the development of lipotoxic 
cardiomyopathy (Walls et al., 2018).  
Interestingly, a recent publication from the CHARGE Consortium found an association 
between high levels of odd-numbered chain saturated fatty acids (OCSFA) C:23 and 9 SNPs 
on CerS4 coding regions. This was done by analysing the circulating OCSFA in 11,494 
European individuals (De Oliveira Otto et al., 2018). Another genome-wide association 
study has found 8 SNPs for Cers4 associated with high levels of VLCFA (Very Long Chain 
Fatty Acid)(Lemaitre et al., 2015). 
All of the above mentioned mammalian CerSs have a conserved putative NLS2 site 
(Appendix Figure 5.7, A). As the NLS2 site was shown to be functional in CerS2 in this 
work (Figure 2.12, 2.13), it will be interesting for future studies in mammals to elucidate 
whether the homeodomain might contribute to the development of obesity-associated insulin 
resistance, and whether also in mammals the interaction with Foxo might play a role in 
mediating transcriptional response. 
In economically well-developed countries, excessive consumption of food and over-
eating has led to a significant portion of the society suffering from metabolic dysfunctions 
such as obesity, lipodystrophy syndromes or insulin resistance. These diseases are often 
associated with a chronic dysregulation of the balance between lipolysis and lipogenesis. In 
response to changing dietary conditions the expression of genes involved in lipid metabolism 
needs to be adapted in order to maintain metabolic homeostasis. However, exact molecular 
mechanisms in these adaptive responses that coordinate genomic response to altered 
metabolic conditions to promote the lipid storage or lipid mobilization still remain largely 
elusive. The identification of a new mechanism for the CerS family member Schlank as a 
central regulator in adaptive response that coordinate genomic response to altered metabolic 
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conditions, represents an important step in unravelling the molecular network underlying 
lipid-based metabolic disorders. 
Moreover, Schlank function in sensing FA and transducing the signal to the level of gene 
expression could have clinical implications in ceramide associated pathologies. As it was 
shown for peroxisomal loss associated diseases (Sellin et al., 2018), many other 
sphingolipidoses or pathologies of the central nervous system such as multiple sclerosis, 
epilepsy, Alzheimer’s or Parkinson’s disease, associated with altered CerS expression or 
altered CerS localization (Wegner et al., 2016; Hannun and Obeid, 2018) might be improved 
by a change in uptake of dietary lipids. This could represent a non-invasive and life-changing 
way of intervention in severe and debilitating diseases.  
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4  Materials and Methods 
4.1 Constructs and fly lines  
 
4.1.1 Vectors 
pUAS-GFP-schlank-aa64–138 (Voelzmannet al., 2016), the complete stretch between the 
first two potential transmembrane domains containing the homeodomain including all NLS 
sequences, was used to produce pP{UAS-schlank-Hox} transgenic flies. foxoRNAi and 
schlankRNAi constructs were obtained from Vienna Drosophila Resource Center (VDRC ID 
respectively dna 4348 and dna 15550. 
4.1.2 Cloning and fly lines generation 
The fly lines SchlankRIVFRTWTHA, SchlankRIVFRTNLS2HA, SchlankAll.SwitchH215DHA and 
SchlankAll.SwitchNLS2HA were generated by homologous recombination and φ mediated 
integration. pP{UAS CerS2NLS2HA}, pP{UAS CerS2H215DHA}, pP{UAS h_elovl4HA} 
were generated by P-element transformation into w1118 flies (BestGene Inc., Chino Hills, 
CA, USA).  
Name Vector Description 
Vector 
Descriptio
n Fragment 
Sites 
Restr
. 
Description 
procedure 
Fly 
Lin
e 
 
Allele switch KIWT 
RIV FRT 
MCS1 FRT MCS3 
pax-cherry  
Schlank-  NheI; 
XhoI  
Cutted from pGE 
attB KIWT  
N 
 
 
 
pUASTCerS2-NLS2 
pUAST CerS2 
cDNA- mutated 
in NLS2 site 
ARAR->ALAL 
from IDT; HA 
Tagged Ct 
EcoRI
; XhoI 
IDT Synthesis 
Synthetic cDNA 
(mouse) 
Y 
 
 
pUAST CerS2-HD215 
pUAST CerS2 
cDNA- mutated 
in H215D from 
IDT; HA 
Tagged Ct 
EcoRI
; XhoI 
IDT Synthesis 
Synthetic cDNA 
(mouse) 
Y 
 
pUAST_elovl4HA 
pUAST elovl4 HA 
From IDT HA 
tagged Ct 
XhoI; 
XbaI  
IDT Synthesis 
Synthetic cDNA 
(human) 
Y 
 
 
pUAST Schlank 
cDNA- mutated 
in H215D from 
EcoRI
; XhoI 
IDT Synthesis  
Synthetic cDNA 
(mouse) 
N 
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pUAST_Schlank-H215D 
HA 
IDT; HA 
Tagged Ct 
 
 
pUAST_Schlank_E118A 
pUAST Schlank 
cDNA- mutated 
in E118A from 
IDT ; HA 
Tagged Ct 
EcoRI
; XhoI 
IDT Synthesis  
Synthetic cDNA 
N 
 
 
miniwhite_SchlankHA 
RIV FRT  Schlank- 
Drosophila 
melanogaster, 
CT HA tag 
NotI, 
AscI 
pGE attB KIWT 
ALK, PCR 
Y 
 
 
miniwhite_Schlank-
NLS2-HA 
RIV FRT mutagenesis 
in NLS2 site; CT 
HA tag 
NotI, 
AscI 
Mutated fragment 
cutted from pGE attB 
KINLS2 
(Mlu1,NdeI), inserted 
in mini white Schlank 
HA 
Y 
 
AlleleSwitch KIWT-H215DHA 
AlleleSwitch 
KIWT;pTV-cherry 
mutagenesis 
in H215D site, 
CT HA tag 
PacI, 
AgeI 
PCR, pGE attB 
H215D  
Y 
 
AlleleSwitch KIWT-NLS2HA 
AlleleSwitch 
KIWT;pTV-cherry 
mutagenesis 
in NLS2 site; CT 
HA tag 
PacI, 
AgeI 
PCR, 
miniwhite_Schlank_ 
NLS2-HA  
Y 
 
AlleleSwitch KIWT-KIWTHA 
AlleleSwitch 
KIWT;pTV-cherry 
Insertion of 
KIWTHA 
PacI, 
AgeI 
PCR, 
miniwhite_SchlankH
A 
N 
 
4.1.3 Fly Stocks 
Flies were kept on standard fly food in plastic vials. Unless differently stated they were 
stored at 18°C or 25°C. The following fly stocks were obtained from the Bloomington Stock 
Centre: w1118; P{cg-GAL4.A}2 (# 7011) and w1118; foxoΔ94/TM6B, Tb1 (#42220), 
Df(1)dx81, w*/Dp(1;Y)dx+1/C(1)M5 (#5281). pP{UAS-schlank NTHA}, pP{UAS-schlank 
CTHA}, pP{UAS-CerS2} (Bauer, et al., 2009), pP{UAS-GFP}, and pP{UAS-schlankNLS2} 
(Voelzmann et al., 2016) and pUAS-GFP-schlank-aa64–138 (Voelzmann et al., 2016).  
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4.2 Life span analysis 
4.2.1 Larvae selection 
For any experiment, only male larvae were taken. Females of homozygous stocks were 
crossed to FM7a, P{Dfd-GMR-nvYFP} carrying males. Eggs were collected for 4 h on apple 
juice agar plates and larvae were sorted for the absence of the dfd-nvYFP marker and 
transferred to a new plate. 
For all experiments with mutant larvae showing developmental delay, if not stated 
otherwise, morphological criteria were used to ensure that wild type and mutant animals of 
the same developmental stage were selected (wandering third instar larvae (L3), a stage 
when feeding has ceased (Ainsley et al., 2008). In particular, schlankKINLS2 larvae were 
staged as developmentally comparable with 96h w1118 or schlankKIWT  when their anterior 
spiracles were open but had not yet protruded from the cuticle and when posterior spiracles 
turned to dark orange. Mutant larvae not showing any developmental delay were staged 
according to hours from AEL.  
 
4.2.2 Survival assay 
    Eggs were collected for 4h and after 24h first instar larvae were selected by the absence 
of the fluorescence marker. 25 larvae were counted and monitored throughout larval, pupae 
and adult stages. The experiments were performed in triplicate.  
4.2.3 Starvation and oil feeding experiments 
Eggs were collected for 4h and after 24h first instar larvae were selected by the absence 
of the fluorescence marker. For starvation, at 90h AEL (or morphological criteria for mutant 
larvae), 10 larvae were washed in PBS to remove any residual yeast on the cuticle surface. 
Then larvae were transferred to a new apple-juice agar plate with fresh yeast for the 
experimental control and in parallel on a PBS-agar plate (1%). To avoid larval escape as 
well as low oxygen levels (when plates are wrapped with paper) a cage for eggs laying was 
placed over the plates. Starvation was conducted for 6h at 25°C. After the starvation time 
larvae were washed in PBS and frozen in TRizol. For lipid rescues, larvae were fed with 
supplementary oils in vivo. Twenty-five larvae were put on an apple juice agar plate with 
yeast with the addition of either 5% coconut oil or olive oil, or cacao butter, or broccoli oil. 
This experiment was performed in triplicate for each oil used. When the larvae reached the 
L3 stage (by morphological criteria), they were washed and frozen in TRizol.  
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4.3 Gal4/ UAS system 
The Gal4/UAS system is a binary system that allows the ectopic expression of transgenes 
(Brand and Perrimon, 1993). The Gal4 gene is encoding for the yeast transcription activator 
protein Gal4 which recognizes and binds to the UAS enhancer (Upstream Activation 
Sequence). The Gal4 is usually expressed under the control of tissue/time specific enhancer. 
 
4.3.1 Rescue experiments 
For rescue experiments, male flies with different schlank or CerS2 variants, combined 
with FM7a, P{Dfd-GMR-nvYFP}1, were crossed with schlankKINLS2 / FM7a, P{Dfd-GMR-
nvYFP}1 P{cg-GAL4.A}2 females, that drives the expression of Gal4 in the fat body organ. 
Hemizygous GFP negative males carried the reintegrated mutant schlankKINLS2 allele. 
Schlank variants and fly lines used in this thesis for rescue experiment are listed above.  
4.4 Flp-FRT system 
The FLP/FRT system is a site-directed recombination system. The recombination enzyme 
Flippase (Flp) recognizes and targets specific DNA regions, flipase recognition target (FRT) 
sites. Initially identified in Saccharomyces cerevisiae, the yeast FLP-enzyme and its FRT 
recombination targets are used in Drosophila (Golic and Lindquist, 1989) to mediate mitotic 
recombination in vivo during development in a controlled manner (Theodosiou and Xu, 
1998). The induction of the recombination events is usually performed by expressing the 
FLP under the control of the heat-shock (hs) promoter allowing the high expression of FLP 
at specific developmental time windows. 
For expression of the H215D-HA from the Alleleswitch KIWT-H215DHA line a heat shock 
CD2 Flp was used (hsFLP y1 w*; act5c promoter FRT CD2stop FRT GAL4, UAS-GFP / 
TM6B, Tb1). Being the Gal4 under control of the actin promoter, the expression of the 
Flippase is ubiquitous.  
AllSwitchKIWT-KIH215DHA;+;+ were crossed with hsFLP y1 w*; +/+; act5c promoter FRT 
CD2stop FRT GAL4, UAS-GFP/TM6B, Tb1 and selected for Cherry fluorescence; and 
absence of Tubby (conferred from TM6B, balancer). At 48h AEL larvae were heat shocked 
for 2 hours at 29°C, (the line confers expression in the fat body organ already at 25°C), after 
48h selected for GFP fluorescence and processed for experiments. 
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4.5 Metabolic labelling of larval lipids  
The metabolic labeling of lipids was carried out by Dr. Bernadette Breiden. TAG, FA, 
and Ceramide synthase activity was determined by measuring de novo TAG, FA and 
ceramide generation after 18h labeling of larvae with [1-14C]-acetic acid. For metabolic 
labeling, larvae were fed with inactivated yeast paste containing [1-14C]-acetic acid 
(61Ci/mol) as a C1-precursor for lipids. Larvae were homogenized, lyophilized and 
weighed. Lipids were extracted in chloroform/methanol/water (2:5:1 v/v/v). Same amounts 
of radioactivity of the desalted lipid extract were applied to each line on the TLC plates. 
Unpolar lipids (fatty acid, triacylglycerol) were separated with n-hexane/diethylether/glacial 
acetic acid (70:30:1, v/v/v) and ceramides with chloroform/methanol/glacial acetic acid 
(190:9:1, v/v/v). Radioactive bands were visualized with a Typhoon FLA 7000 (GE, 
Germany) and quantification was performed with the image analysis software 
ImageQuantTL (GE, Germany). Lipids were identified using commercially available 
reference standards (ceramide (C18:1/C18:0) (Sigma, Germany), phytoceramide 
(Cosmoferm, Delft, Netherlands), trioleoylglycerol (Sigma, Germany), and stearic acid 
(Fluka))  
 
4.6 Triacylglycerols (TAG) 
The TAG content was quantified by a coupled colorimetric assay. Circa 10 L3 of different 
genotypes were homogenized in 100μl of PBS using the Precellys 24 (3x 15 sec, 5000 Upm) 
and frozen in liquid nitrogen. The lyophilization was performed overnight by Dr. Bernadette 
Breiden. The dry weight was determined by weighting the samples after lyophilization and 
the values were used to normalize TAG amount. Samples were resuspended in 400l of 
PBST and after centrifugation of 13,000 rpm for 3 min (4°C) the supernatant was transferred 
to new Eppendorf tubes and heated for 10 min at 70°C. Two 1.5ml Eppendorf tubes were 
used per each sample with 20l of the samples in parallel two tubes with the glycerol 
standards (1,0 mg/ml, 0,5 mg/ml, 0,25 mg/ml, and 0,125 mg/ml) and PBST (blank) were 
also prepared. To measure free glycerol, one of the tubes was treated with 20l of PBST, 
while the other one was treated with 20l of triglyceride reagent (containing lipases to break 
down the TAG). Next, the probes were incubated for 45 min at 37°C. Afterwards the samples 
were centrifuged at 13,000 rpm for 3 min and 30l of the supernatant of each sample was 
transferred to a 96 well plate. In the next step, 100l of free glycerol reagent was added to 
each well and mixed. The plate was sealed with parafilm and then centrifuged to remove 
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condensed water and air bubbles. Subsequently, the plate was incubated for 5 min at 37°C. 
The absorbance was then measured at 540nm using the TECAN plate reader. The TAG assay 
was performed in triplicates for each of the genotypes and always included KIWT control. 
 
4.7 Free Fatty acid assay (FFA) 
FFA or Non-esterified fatty acids (NEFA) were measured by an adaptation of the copper-
soap method (Tinnikov et al., 1999). In brief, three 3rd instar larvae were weighed and 
homogenized in 20μl of 1M phosphate buffer per mg tissue. 25μl of the supernatant were 
transferred to 500μl of Chloroform/Heptane 4:3, and lipids were extracted by shaking the 
vial for 5 min. Unspecific background provoked by phospholipids was circumvented by 
addition of 23 mg of activated silicic acid. 300μl of the chloroform phase were transferred 
to 250μl of Cu-TEA (copper-triethanolamine). After shaking and centrifuging, 150μl of the 
organic phase were transferred to fresh tubes. Liquid was evaporated in a 60 °C heat block, 
and lipids were dissolved in 100μl of 100% ethanol. Copper was detected by complexation 
with a mixture of dicarbazone - dicarbazide, and the color intensity was measured in a 96 
well plate at 550 nm in a TECAN platereader (Bülow et al., 2017; Sellin et al., 2018). 
 
4.8 Ex vivo culture  
Ex vivo organ culture was established. After being washed in PBS, third instar larvae were 
carefully opened and incubated in ice cold Glucose-free Ringer’s solution supplemented 
with different BSA-conjugated fatty acids (C12, C14, and C16) to a final concentration of 
200µM for 6h at 4°C (several temperature and conditions were tried with the mentioned 
resulting the best for tissues morphology). BSA was used as control treatment. For different 
experimental condition, Etomoxir or Fumonisin B1 were added in parallel to a final 
concentration of 200µM and 50µM or 100µM for the latter (Xu et al., 2012). Following 
incubation, the open larvae were then washed and fat bodies and gut were quickly dissected 
in ice cold Ringer´s solution; and subsequently frozen in in 200µl of TRIzol in liquid 
nitrogen. 
 
 
 59 
4.9 Immunohistochemistry 
Larvae were inverse-prepped in ice-cold PBS, fixed for 60 minutes in 4% methanol-free 
formaldehyde at room temperature. After several washes in Phosphate-buffered saline with 
0.2-0.3% Triton X 100 (PBT) and incubation for 30 minutes in blocking solution (5% 
donkey serum in PBT), primary antibodies were incubated over night at 4°C. Samples were 
then washed and incubated in blocking solution as previously described. Secondary 
antibodies were added for 1.5h at room temperature followed by several washing steps.  
 
4.9.1 Quantification of nuclear versus cytoplasmic Schlank in fat body cells 
Cells were imaged for Lamin Dm0 (Inner nuclear membrane; INM), DAPI, Schlank or 
Spectrin (Cell membrane; CM) and Schlank. The nuclear area was defined as DAPI / Lamin 
Dm0 stained region. The cytoplasmic area was defined as Spectrin area minus nuclear area. 
Mean fluorescent intensity (MFI) ratio of Schlank fluorescence of nuclear versus 
cytoplasmic area per cell was determined. Quantification was done using ImageJ software. 
Statistical difference in the distribution of the ratios was tested via Mann-Whitney U test.  
 
4.9.2 Size Determination of fat body cells 
Cells were imaged for Lamin Dm0 (INM), Schlank, and Spectrin CM), the cell area was 
defined by Spectrin and outlined by “Hand” tool. Cells at a comparable confocal plane were 
compared using lamin staining. Cell area was determined using ImageJ software. Statistical 
difference in the distribution of the ratios was tested via Mann-Whitney U test. 
 
4.10 RNA extraction and quantitative Real Time PCR (qRT-PCR) 
Isolation of total RNA was performed in TRizol (Invitrogen). cDNA was transcribed 
using Qiagen QuantiTect Kit. Realtime PCR was performed in a reaction mix containing 
cDNA template, primer pairs and iQ SYBR Green Supermix (BIO-RAD). The experiments 
were performed in an iQ5 Real-Time PCR Detection System from BIO-RAD. Ribosomal 
protein L32 (rp-49) was used as reference gene. For qRT primers see table below. All 
template reactions were done in parallel and repeated with independently isolated RNA 
samples from different larval or cell collections. 
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4.10.1 RNA isolation for RNA-seq 
For RNA isolation, fat body cells (from ~30 animals per sample) were isolated and 
subsequently lysed in TRIzol (Invitrogen) and total RNA was extracted. The quality of the 
RNA was assessed by measuring the ratio of absorbance at 260nm and 280nm using a 
Nanodrop 2000 Spectrometer (Thermo Scientific) as well as by visualization of the integrity 
of the 28S and 18S bands via a RNA analysis ScreenTape assay on a 2200 TapeStation 
instrument (Agilent). 
 
4.10.2 qRT-PCR primers 
Name Primer Primer Sequences (F-R) 
Lip 3 5´-TGAGTACGGCAGCTACTTCCCT-3´ 
5´-TCAACTTGCGGACATCGCT-3´ 
Magro 5´-GCACCCACCCACTTGTACTC-3´ 
5´-GATCGTTGACCAGCTCCTTC-3´ 
CG6295 5´-GGAGGACCAGCCGTGGATA-3´ 
5´-ATCTCTGGCTCGCACTTCAAC-3´ 
CG8093 5´-AGTACGATGTGGAGGGCATC-3´ 
5´-ATACCTAAGGCGATCCACGT-3´ 
CG6277 5´-TGGCATTCTTTGCTCTGG-3´ 
5´-ACTCGGAAGTGCCATCCT-3´ 
Bmm 5´-ACGCACAGCAGCGACATGTAT-3´ 
5´-CTTTTCGCTTTGCTACGAGCC-3´ 
Thor 5´-CATGCAGCAACTGCCAAATC-3´ 
5´-CCGAGAGAACAAACAAGGTGG-3´ 
InR 5´-AACAGTGGCGGATTCGGTT-3´ 
5´-TACTCGGAGCATTGGAGGCAT-3´ 
SREBP 5´-CGCAGTTTGTCGCCTGATG-3´ 
5´CAGACTCCTGTCCAAGAGCTGTT-3´ 
DHR96 5´-CAAAGAGAGCATATTTAGGATACCAAG-3´ 
5´-CACAGAACCCAC GCTTCCAAG-3´ 
Ceramidase-RA 5´-CCAAGTCCGCCGTACATGAAT-3´ 
5´-TGCGACTTCACGTAGCCAAAG-3´ 
Ceramidase-RB 5´-GTCGGCAGTCTTCTTTTCGTG-3´ 
5´-CACAGGAAACTTACGGCCAGA-3´ 
Ceramide kinase 5´-GTTGCCTGGACCTGATTCTC-3´ 
5´-GGCAAATTGCGAATATCACC-3´ 
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Serinepalmitoyl 
transferase 
5´-ACCCTCTACGAACTGAACAC-3´ 
5´-CGGCACAAAGGCAAAGGA-3´ 
Sphingomyelin-
synthase-related (SMSr) 
5´-TTCAGGGATGCGAGTGTG-3´ 
5´-ACGAATGTGGAAGAGCGAAT-3´ 
Glucosylceramidase 5´-CACGTGCTCTGTTGGTTCC-3´ 
5´-CCAGCCAACGACGAACTC-3´ 
Fatty Acid Synthase 5´-CCCCAGGAGGTGAACTCTATCA-3´ 
5´-GACTTGACCGATCCGATCAAC-3´ 
Rp-49 5´-TCCTACCAGCTTCAAGATGAC-3´ 
5´-CACGTTGTGCACCAGGAACT-3´ 
 
4.11 Cell Culture and transfection 
Drosophila Schneider cells (S2) were grown in Schneider’s Medium supplemented with 
10% heat inactivated fetal bovine serum and 1% penicillin/streptomycin (Sigma, St Louis, 
USA). Transfection was performed approx. 12h after plating of S2 cells using Effectene 
(Qiagen) according to the manufacturer’s instruction. Starvation and FA Treatment were 
done in Serum Free Optimem with or without BSA-FA for the indicated time. To allow any 
ectopic expression efficiently, S2 cells were harvested 48h after transfection with the 
corresponding plasmids. 
4.11.1 Luciferase Assays 
Luciferase assays was performed using the Dual-Luciferase® System (Promega). After 
48h from transfection in a 24-well plate, the media was removed and S2 cells were 
resuspended in100µl of 1X Passive Lysis Buffer (PLB), and left in shaking for 15 minutes 
at room temperature. The whole lysates (included cell debris) were transferred in tubes on 
ice and a centrifuge at 10000g at 4°C was performed for 1 minute. After, the supernatant 
was readily transferred in a fresh tube (on ice) and the debris discarded. The samples were 
stored at -20°C up to 1 months. For the luciferase assay, 25µl of lysate were transferred to a 
micro-96 well white plate (costar® 3693 EIA/RIA plate, 96 well half area). Luciferase 
activity measurements were done using a MicroLumatPlus LB 96V luminometer (Berthold 
Technology). Immediately before the measurements, 25µl (Scaled down from the 100µl 
described from the manufacturer) of the first component Luciferase assay reagent (LAR; 
Substrate for Firefly luciferase) was added to each well. The measurement was set for 3 sec 
for each well. Subsequently 25µl of the Stop&Glo (Substrate for Renilla luciferase) were 
added to each well and measurements were repeated. Value of Firefly <500 were not taken 
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into account for the quantification because comparable to the measurement for LAR alone. 
Each experiment was repeated three times and is the average of the reading of three different 
transfected wells. 
4.11.2 Antibody Staining 
For immunohistochemical staining were used: anti-Schlank-CT from guinea pig or sheep 
(α−Schlank) 1:50 (see Voelzmann, Bauer, 2011), anti-HA (α−HA, rat, 1:100; clone 3F10; 
Roche); anti-Spectrin (α−Spectrin; mouse, 1:40) Developmental Studies, Hybridoma Bank 
(DSHB) and mouse anti-Lamin Dm0 (DSHB) 1:100. Tissue or cell were mounted with DAPI 
Fluoromount-G (SouthernBiotech). 
 
4.11.3 Quantification of nuclear Schlank in S2 cells 
Cells were imaged for Schlank (α-Schlank-CT, endogenus) or HA (α-HA; expression of 
UAS-schlank NTHA (HA-WT)) and DAPI fluorescence. The nuclear area was defined as 
DAPI and Cytoplasm as total Schlank signal minus nuclear area. Mean fluorescent intensity 
(MFI) ratio of Schlank / DAPI of nuclear versus cytoplasmic area per cell was determined 
and quantified using the Image J “Intensity Ratio Nuclei Cytoplasm Tool” (Volker Baecker, 
2012) and plotted as MFI (nucleus / cytoplasm). Each of the measurement is shown in the 
dot plot. Statistical difference in the distribution of localization were tested via one-way 
anova with Bonferroni post-test. 
 
4.12 Chromatin Immunoprecipitation (ChIP) 
S2 Cells were crosslinked with formaldehyde (1% final concentration). The reaction was 
stopped by the addition of glycine (0.125 M for 5 min at room temperature). Cell pellets 
were lysed in L1 buffer (2 mM EDTA, 50 mM Tris–HCl (pH 8.1), 0.1% Nonidet P-40, 10% 
glycerol and protease and phosphatase inhibitors) for 20 min at 4°C in rotation. The lysates 
were homogenized and then centrifuged at 5000 rpm for 5 min at 4°C. Nuclear pellets were 
resuspended in L2 buffer (5 mM EDTA, 50 mM Tris–HCl (pH 8.0), 1% SDS (completed 
with protease and phosphatase inhibitors) and kept on ice for 10 min. Nuclear lysates were 
sonicated to obtain chromatin fragments of an average length of 200 to 700 bp and 
centrifuged at 10,000 rpm for 10 min at 4 °C. The sonicated supernatant fractions were 
diluted 5-fold with dilution buffer (5 mM EDTA, 50 mM Tris–HCl (pH 8.0), NP40 0.5%, 
NaCl 200 mM and protease and phosphatase inhibitors). For each condition 20025µl of 
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diluted chromatin were incubated with a 50 % Protein A+ 50% Protein G Sepharose 
(Immunoprecipitation starter kit, Amersham Biosciences, Piscataway, NJ) saturated with 
salmon sperm for 1h at 4°C on a rotating platform. The precleared chromatin samples were 
centrifuged at 14,000 rpm for 5 min and incubated with the respective antibodies overnight 
with gentle rotation at 4°C. Immunoprecipitated samples were recovered by incubation with 
saturated Protein A and G Sepharose on a rotating platform for 2 h at 4°C. Before the samples 
were washed, the supernatant of the no-antibody control was taken as input sample. Each 
sample was washed with 1ml of Low Salt buffer (0.1% SDS, Triton-X-100, 2 mM EDTA, 
20 mM Tris-HCl pH=8.1, 150 mM NaCl); high Salt buffer (0.1% SDS, Triton-X-100, 2 mM 
EDTA, 20 mM Tris-HCl pH=8.1, 500 mM NaCl); LiCl Buffer (0.25 M LiCl, 1% NP40, 1% 
deoxycholate, 1 mM EDTA, 10 mM Tris-HCl pH=8,1) and TE Buffer (10 mM Tris-HCl, 1 
mM EDTA pH=8). Samples were eluted with elution buffer two times 150µl (1% SDS, 0.1 
M NaHCO3) and then treated with RNaseA for 10 minutes at room temperature. The protein-
DNA crosslinking was reversed at 67°C overnight. NaHCO3 in each sample was neutralized 
by Tris-HCl (pH 6-7.5). Samples were treated with Proteinase K for 2h at 56°C. 
Phenol/Chloroform was used for DNA extraction. 1ul of immunoprecipitated DNA was used 
for analysis by qRT-PCR. 
 
4.12.1 Linker-mediated PCR 
The following linkers were used:  
5´P-AGAAGCTTGAATTCGAGCAGTCAG (24 mer- 5´phosphorylated) 
5´-CTGCTCGAATTCAAGCTTCT (20 mer).  
10µM of each primer were let annealed in a PCR cycle, (95°C for 5 min; 70°C for 5 min, 
55°C for 5 min) and stored at -20°C.1µl of 1µM of annealed linkers were ligated with 1µl 
of T4 DNA Ligase (NEB) and DNA Ligase buffer to 7µl of immunoprecipitated material 
overnight (ON) at 16°C. Subsequently a PCR was run using 10µl of ligation mix; with 1µl 
of 20-mer linkers (100 µM) in a final volume of 100µl for the reaction (55°C for 2 min, 72°C 
for 5 min, 94°C for 5 min, [94°C for 1 min, 55°C for 1 min, 72°C for 1 min] x 20 cycle; 
72°C for 5 minutes, 4°). The PCR reaction was repeated by using 10µl of PCR instead of 
10µl ligation as template. The PCR was then run on 1.5% Agarose Gel.  
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4.12.2 Primers for qRT-PCR ChIP 
Name Primer Primer Sequences (F-R) 
Lip 3_prom 5‘-CACGAGGTGGTCACCAGTGACA-3‘---5‘-
CTCAGCATGCCGTGCATGAGGA-3‘ 
Magro_prom 5´-ATTTTTAAACTAAACCTCAA-3´--5´-
ATCTGCTGGTCGAAACCCTG-3´ 
sprouty 5´-AATCGGCGAGGATGAGTG-3´---5´-
GACGGCAGGTGCAAGACAG-3´ 
miR 278 5´-CGGGTCGGTGGGACTTTC-3´---5´-
GACGGCAGGTGCAAGACAG-3´ 
 
4.13 Immunoprecipitation and Immunoblotting 
Immunoprecipitation and immunoblotting were done as described earlier (Bauer et al., 
2006). Briefly, S2 cells or larvae were homogenized in RIPA buffer (150mM NaCl, 1% 
IGEPAL CA-630, 0.5% Sodium Deoxycholate, 0.1% SDS, 50mM Tris (pH 8.0), 
supplemented with protease inhibitors (CompleteTM; Roche, Indianapolis, USA), and 
centrifuged at 10,000rpm for 10 min at 4oC. The supernatant was used for determination of 
protein content, immunoblotting and/or immunoprecipitation. Whole cell S2 lysates (50µg 
of protein) were separated by 15% SDS-PAGE and transferred to a PVDF-membrane 
(Immobilon P transfer-membrane; Millipore). The immunoblot membrane was blocked with 
non-fat dry milk in TBS plus 0.05% Tween (TBST) and then incubated with either anti‐HA 
(rat, 1:500; clone 3F10; Roche), anti-GFP (mouse, 1:500, Santa Cruz), anti‐schlank (guinea 
pig, 1:400), α-actin (rabbit IB: 1:1000 Sigma) antibodies. After washing, bound antibodies 
were visualized with peroxidase–conjugated donkey anti-rabbit, donkey anti-mouse or 
donkey anti-rat IgG (1:15000) using the ECL system (Pierce™ ECL Western Blotting 
Substrate, TermoFisher Scientific).  
Co-immunoprecipitation was performed using the immunoprecipitation starter pack 
(Amersham Biosciences, Piscataway, NJ). To avoid the nonspecific binding of proteins to 
A/G-Sepharose, preclearing of the cell-lysates was performed for three hours at 4°C in the 
presence of protein A/G-Sepharose. The cleared supernatant was incubated overnight with 
α-HA or α-GFP antibodies in a final volume of 500µl. 50µl protein A/G- Sepharose was 
added to each mixture and incubated for 3h at 4oC. The beads were washed three with 1ml 
RIPA-buffer and two times with 1ml PBS. resuspended in SDS-Page sample buffer, and 
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boiled for 3 min. Samples were run on a 12% SDS-gel, transferred to a PVDF-membrane 
(Immobilon P transfer-membrane; Millipore) and the blot processed as described above. 
4.14 RNA-Sequence analysis  
4.14.1 Generation of cDNA libraries 
Total RNA was converted into libraries of double stranded cDNA molecules as a template 
for high throughput sequencing following the manufacturer’s recommendations using the 
Illumina TruSeq RNA Sample Preparation Kit v2. Shortly, mRNA was purified from 100ng 
of total RNA using poly-T oligo-attached magnetic beads. Fragmentation was carried out 
using divalent cations under elevated temperature in Illumina proprietary fragmentation 
buffer. First strand cDNA was synthesized using random oligonucleotides and SuperScript 
II (Invitrogen). Second strand cDNA synthesis was subsequently performed using DNA 
Polymerase I and RNase H. Remaining overhangs were converted into blunt ends via 
exonuclease/polymerase activities and enzymes were removed. After adenylation of 3′ ends 
of DNA fragments, Illumina indexed PE adapter oligonucleotides were ligated. DNA 
fragments with ligated adapter molecules were selectively enriched using Illumina PCR 
primer PE1.0 and PE2.0 in a 15 cycle PCR reaction. Size-selection and purification of cDNA 
fragments with preferentially 200-300 bp in length was performed using SPRIBeads 
(Beckman-Coulter). The size-distribution of cDNA libraries was measured using the high 
sensitivity D1000 assay on a 2200 TapeStation instrument (Agilent). cDNA libraries were 
quantified using KAPA Library Quantification Kits (Kapa Biosystems). After cluster 
generation on a cBot, a 75 bp single-end run was performed on an Illumina HiSeq1500. 
4.14.2 Preprocessing RNA-seq 
After base calling and de-multiplexing using CASAVA version 1.82, the 75 bp single-
end reads were aligned to the Drosophila Melanogaster reference genome dm6 from UCSC 
by HISAT2 version 2.0.5 using the default parameters. After mapping of the reads to the 
genome, we imported the data into Partek Genomics Suite V6.6 (PGS) to quantify the 
number of reads mapped to each gene annotated in the RefSeq dm6 annotation downloaded 
in October 2016. The raw read counts were used as input to DESeq2 for calculation of 
normalized signal for each transcript using the default parameters. After DESeq2 
normalization, the normalized read counts were imported back into PGS and floored by 
setting all read counts to at least a read count of 1. Subsequent to flooring, all transcripts 
having a maximum over all groups means lower than 10 were removed. After dismissing the 
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low expressed transcripts the data comprised of 10.760 present genes. RNA-seq data can be 
accessed under GSE98800. 
 
4.14.3 Statistical and descriptive bioinformatics of transcriptome data 
A one-way analysis of variance (ANOVA) model was performed to calculate the 1.000 
most variable and the differentially expressed (DE) genes between all groups. DE genes (664 
genes) were defined by a fold change (FC) > 3 or < -3 and a p-value < 0.05. To visualize the 
structure within the data, we performed Principle Component Analysis (PCA) on all genes 
and hierarchical clustering (HC) on the 1.000 most variable genes with default settings in 
PGS based on the p-value of the expression values of all samples across all conditions.  
To define differences and similarities in transcript expression among the groups, we 
performed co-expression network analysis based on Pearson’s correlation coefficients 
(correlation r-cutoff 0.98) by using BioLayout Express3D (Theocharidis A et al.). The set of 
all present genes was used as the input for the network analysis. We visualized the network 
analysis using Cytoscape and colored the nodes within the network, representing the genes, 
according to their FC among the two conditions. 
To assess the functionality of the genes with the highest and lowest fold changes and their 
nearest neighbors in the co-expression network, we performed a gene ontology enrichment 
analysis using the PANTHER classification system (Mi H et al.). GO-terms were considered 
significantly enriched with a Bonferroni corrected p-value < 0.05. 
 
4.15 Image acquisition and processing 
Images were taken with a Zeiss LSM710 confocal microscope and analysed with ImageJ 
(National Institute of Health, USA Schneider, Rasband, Eliceiri 2012). Where needed, 
brightness or contrast was adjusted for the whole image in Adobe Photoshop. For 
comparative stainings, images were not post-processed. Image panels were assembled in 
Adobe Illustrator software 
 
4.16 Statistical analysis  
Significance was tested using a 2-tailed heteroscedastic Student’s t-test (Microsoft Excel) 
with at least 3 independent biological replicates (n), with Mann-Whitney U test or with one-
way ANOVA where indicated (GraphPad Prism).*p<0.05, **p<0.01, ***p<0.001.  
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5 Appendix 
5.1 Schlank locus gene expression verification 
After reintegration Schlank and other genes in close proximity were analysed for mRNA 
levels by qRT-PCR, beside a reduction in Schlank expression for SchlankKO no differences 
were observed in expression for any of the other genes and genotypes.  
 
Figure A5.1. Reintegration analysis: quantification of mRNA levels by qRT–PCR. A) Strongly reduced 
Schlank mRNA expression in SchlankKO mutants in comparison with w1118, KIWT, KIE118A, KINLS1, KINLS2 
and KIH215D animals. Residual quantities of Schlank are due to Schlank maternal and zygotic supply (Bauer 
et al., 2009). Transcripts levels of Schlank or of CG3781 and spx laying within or at the 3’ region of the Schlank 
gene locus, respectively, resulted similar in KIWT, KIE118A, KINLS1, KINLS2, KIH215D and w1118 confirming 
the expression of reintegrated gDNA. B) Comparison of KIWT gene expression with other wild type flies. No 
change in gene expression is observable for genes involved in lipid metabolism and insulin signalling. 
Normalized on rp-49 expression levels in w1118.Error bars indicate SEM. 
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5.2 KINLS2 mutant: cell size and nuclear localization in fat body cells 
Representative images for KIWT and KINLS2 fat body cells (Sociale et al., 2018).  
 
Figure A5.2. Fat body cells of KINLS2 and KIWT (L3) larvae. A) Cells were stained for Lamin Dm0 to 
mark the nuclear membrane, Spectrin to mark cell membrane. B) Schlank nuclear localization in fat body cells. 
Cells were stained with an α -Schlank antibody recognising the C-Terminal of the protein (α-Schlank CT, 
magenta), with Lamin and Spectrin to mark the nuclear membrane and the cell membrane (green), respectively. 
 
5.3 Sphingolipidomic analysis of KINLS2  
To have a complete picture of KINLS2 sphingolipidome, several samples of different 
larvae stages and one day old flies were sent for Mass Spec analysis, performed by Johanna 
Von Gerichten (AG R Sandhoff, DFKZ Heidelberg). At the early larval stage, the overall 
ceramide levels are similar to control larvae, accordingly with the de novo ceramide 
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generation. However, during the prolonged larval stage total ceramide levels decrease up to 
50 %. Different TLC using several sphingolipid marker were performed, showing the 
enrichment of an atypical band that, to date, could not be yet identified. A possible 
explanation for the reduced ceramide levels in development might be found in an altered 
regulation of the sphingolipid signalling pathway. For this reason, gene expression of several 
enzymes involved in sphingolipid metabolism was tested. All of the tested genes no matter 
if up- or downstream Schlank resulted to be upregulated in comparison with KIWT control 
(Figure A5.3, A) meaning that the difference in ceramide metabolism might be due to a 
deregulation of gene expression resulting in a changed ceramide homeostasis e.g. by 
metabolizing it into complex sphingolipids or altered degradation. 
Figure A5.3. Analysis of 
transcript levels of genes of enzyme 
involved in sphingolipid 
biosynthesis. A) Gene expression 
levels in L3 KINLS2 mutant larvae. 
Acronyms: d_asah, ceramidase (two 
isoforms RA and RB). CerK, 
Ceramide Kinase. GluCS, 
Glucosylceramide Synthase. SmsR, 
sphingomielynase related. Spt, Serine-
palmitoyl-transferase. Transcript 
levels normalized on KIWT transcripts 
levels (spotted line) were determined 
using qRT-PCR (n = 3). Normalized 
on rp-49 transcript levels Error bars indicate SEM, *** p<0.05, ** p<0.01, *p<0.001. 
 
5.4 Nuclear localization and in vivo starvation  
Changes in nuclear localization upon nutrients availability are confirmed in vivo in W1118 
fat body cells (Sociale et al., 2018). Ectopic expression of homeodomain (aa 64-138) 
(localizing exclusively nuclear in cell culture experiments, Voelzmann et al., 2016) in 
hemizygous schlankG0061 mutants, which strongly upregulated lip3, as KINLS2 mutants. The 
construct was expressed using pumpless-Gal4-driver lines (pplGal4). Lip3 expression 
remained unchanged (Figure A5.4, B). In contrast the expression of a construct containing 
the N-Terminal of the protein (first TM domain) and the homeodomain (localizing mainly 
nuclear in cell culture experiments), rescued lip3 upregulation in schlankG0061 (Voelzmann 
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et al., 2016). Supposing that in order to exert its function Schlank homeodomain needs to be 
anchored to the membrane.  
 
Figure A5.4. Schlank nuclear localization and lip3 expression. A) 
Confocal sections of an immunofluorescence staining of L3 larval fat 
body using α-SchlankCT antibody (green) and DAPI (magenta). 
Upper and lower panel depict dissected fat bodies from feeding and 
starving (6h) larvae showing more and less DAPI-Schlank co-staining, 
respectively. Scale bar indicates 20μm. Upon starvation, the 
colocalization of Schlank and DAPI is decreased. B) Transcript levels 
of Iip3 in L3 SchlakG0061 mutant larvae upon expression of the 
homeodomain stretch (aa 64-138) under control of the cgGal4 driver 
line. SchlankG0061 larvae carrying the pplGal4 (Zinke et al., 2011) 
driver line but not expressing Schlank variants were used as control. 
The homeodomain alone does not rescue the Schlank phenotype. 
Normalized on rp-49 transcript levels Error bars indicate SEM. 
5.5 Generation of Allele-Switch lines 
The Allele switch lines represent a tool of great value to study Schlank function in 
different organs and tissues during development. Since Hox- proteins are usually necessary 
during development, these lines are useful to understand in which stage and tissue Schlank 
transcriptional regulation (AllSwitchKINLS2) or enzymatic activity (AllSwitchKIH215D) are 
necessary to produce fly lacking any pathological phenotypes. In the scheme below is 
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represented the schematic of the reintegration and of the locus prior or after Flippase 
recombination event.  
 
Figure A5.5. Reintegration scheme for Allele Switch lines. A) A 2.4 kb gDNA that encompassing exons 2-6 plus the 3’ 
UTR sequence of Schlank was deleted and attP sites were inserted. B) The w+, SchlankKO lines is referred to as Schlank 
knockout line. C) After recombination events, the w-, SchlankKO line, the founder line, was used to reintegrate target 
constructs into the attP site. gDNA containing the deleted genomic DNA WT and a mutant H215D-HA (or C´ SchlankNLS2-
HA or C´´SchlankWTHA, as control lines) in a pGE-attB-RIV plasmid used for reintegration at the Schlank target locus of the 
Schlank founder line to generate the schlank-AlleleSwitch KIWT-KIH215DHA allele D). E) Schematic of Schlank locus after 
Flipping out WT locus. Pax-Cherry marker is expressed during larval stage in the nervous system and during adult in the 
eyes (modified from Sociale et al., 2018).  
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5.6 Bioinformatics analysis for low complexity regions and phosphorylation sites 
within Schlank protein sequence 
Low-complexity regions (LCRs) are amino acid sequences that contain repeats of single 
amino acids or short amino acid motifs (Green and Wang, 1994). While many LCRs are of 
unknown function, there are examples of LCRs playing various functional roles, including the 
modulation of protein– protein interactions (Xiao and Jeang, 1998), protein–nucleic acid interactions 
(Shen et al., 2004), and protein subcellular localization (Salichs et al., 2009). Expansion or 
contraction of LCRs can therefore potentially impact protein function (Toll-Riera et al., 2012). The 
analysis with the scanning tool DisEMBL 1.5 a predictor of intrinsic protein disorder revealed that 
beside the un-surprised homeodomain region (aa 50 to 125) a LCR is present at the CT-portion of 
Schlank present LCR (Figure A5.6, A, A´). LCRs are common in DNA-binding proteins and play a 
crucial role by increasing the affinity and specificity of DNA binding facilitating the helices loops. 
Intrinsically unstructured regions assist protein-DNA interactions in various mechanisms, and are 
usually responsible for co-factor binding and interactions. In the context of Schlank-Foxo interaction, 
would be interesting to study the role of the CT tail. DisEMBL analyses three different parameters 
to identify LCRs (Linding et al., 2003): 
Loops/coils as defined by Kabsch and Sander, 1983. Loops/coils are not necessarily disordered; 
however, protein disorder is only found within loops. Representing a necessary but not sufficient 
requirement for disorder.  
Hot loops constitute a refined subset of the above, namely those loops with a high degree of 
mobility as determined from Cα temperature factors (B factors). It follows that highly dynamic loops 
should be considered protein disorder. Several attempts have been made to try to use B factors for 
disorder prediction (Zoete et al., 2002). 
Missing coordinates in X-Ray structure (remark465 entries in PDB) in fact, most often reflect 
intrinsic disorder, and have been used early on in disorder prediction (Li et al., 2000).  
On the other hand, phosphorylation of cargos trafficking between the cytoplasm and nucleus is 
an important step to regulate nuclear availability, which directly affects gene expression (Nardozzi 
et al., 2010). For this reason a study for phosphorylation sites was carried on using two different 
bioinformatics tools NetPhos 2.0 and GPS 2.0 (Xue et al., 2008) (Figure A5.6, B, B´, B´´). NetPhos 
is a neural network-based method for predicting potential phosphorylation sites at serine, threonine 
or tyrosine residues in protein sequences (Blom et al., 1999), while GPS 2.0 is a tool to predict kinase-
specific phosphorylation sites 
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Figure A5.6. Output of bioinformatics analysis for LCR and phosphorylation. A) Output graph for disorder prediction 
where the aa sequence is plotted versus the disorder probability. The program recognises as LCR the regions that exceed 
the threshold (red, blue, green horizontal cut lines) for the three criteria previously described. Only the homeodomain region 
and the CT region meet the criteria. The yellow box highlight the region with the highest probability, and in A´) is shown 
the same region in protein structure. The output in B) show the possible phosphorylation sites one of which within the 
homeodomain, flanking the bipartite NLS2 site (T in green, B´) comes out also from the GPS 2.0 analysis, with one of the 
highest scores (T in re, B´´) 
 
5.7 Protein alignment for NLS2 site 
The mutation in the NLS2 site affected two arginine within the homeodomain (position 
50-52 of the homeodomain or position 122-124 of protein sequence). The NLS2 site is 
conserved in all the mammalian CerSs (mCerSs) except CerS3, which nevertheless still 
contains the two Arginines (R) that are mutated in the NLS2 mutants, one of which in 
position 50 (RLRR to ALAR), is described to be crucial for DNA binding for 
homeodomain proteins (Bürglin and Affolter, 2015). Experimental evidences showed that 
the transcriptional regulation of CerS2b in zebrafish is dependent on the intact RRRR 
region (Mendelson et al., 2017). 
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Figure A5.7. Partial protein alignment for homeodomains. The alignment is for the area of the homeodomain affected 
by the DNA-binding abolishing mutation NLS2. The first R in magenta is described as critical residue for DNA binding in 
Homeodomain TF. The two R are conserved among different species. In the Drosophila (D) Schlank, in the mammalian 
(M) CerSs (2-6), in (e.g.) the CerS2b (e.g.) of Zebrafish (DR, Danio Rerio).  
 
5.8 Verification of ectopic human Elovl4 expression in S2 cells 
Elovl4 is a member of the Elongases family, ER multi-transmembrane proteins that 
catalyse the first and limiting reaction of the long-chain fatty acids elongation cycle. In 
mammals elongases are essential in the biosynthesis of fatty acids longer than C12. For 
instance, elovl1 is responsible of specifically elongating C24:0 and C26:0 acyl-CoAs, 
participating in the production of saturated and monounsaturated VLCFA of different chain 
lengths that are involved in multiple biological processes as precursors of membrane lipids 
and lipid mediators. It has been shown, to play a critical role in early brain and skin 
development (Ohno et al., 2010). In collaboration with Roger Sandhoff (DFKZ, Heidelberg) 
the human elovl4-HA was cloned in a pUAST vector and tested for expression in S2 cells 
before embryo injection. S2 cells derive from a primary culture of late stage Drosophila 
melanogaster embryos (20-24h old), likely from a macrophage-like lineage. S2 cells start to 
differentiate in culture around passage 15th. For this reason every experiment in this thesis 
was performed with freshly thaw S2 cells. Even though, when S2 cell were transfected with 
pAcGal4 and pUASTElovl4-HA, to express the human elovl4, it was serendipitously noticed 
that S2 cells would differentiate (Figure A5.8, A). It is known that Elovl proteins are 
involved in Drosophila sperm development but only few of them have been studied so far 
(Jung et al., 2007).  
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Figure A5.8. Verification of human Elovl4 expression in S2 Cells. Representative 
 images of S2 cells After transfection 48h from transfection. S2 cells were stained for 
DAPI (blue), Lamin Dm0 (green) and Elovl4 using α-HA antibody (magenta).  
Cells positive for HA  expression change morphology in comparison with spherical S2 
 cells not expressing Elovl4-HA. Scale bars indicate 10μm.  
 
5.9 Verification of overexpression constructs and IP 
Verification of newly generated UAS-constructs and pull down, IP.  
 
 
Figure A5.9. Verification of pUAST lines. A) Verification of the expression of HA-WT, HA-NLS2, H215D-HA protein 
in S2 cell extracts used for immunoprecipitation applying an α-HA antibody for immunoblotting. B) Verification of CerS2-
NLS2-HA, CerS2-H215D-HA protein after overexpression in S2 cells. Immunoblot using an α-HA antibody shows a 
specific band corresponding to the predicted size for the CerS2 protein around 46 kDa. C) Verification of the CerS2-NLS2-
HA and CerS2-H215D-HA fusion protein upon expression in the fat body using the cgGal4 fat body driver.  
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Acronyms  
4E-BP Eukaryotic Initiation Factor 4E Binding Protein, Thor 
A Alanine 
aa amino acids 
Acyl-CoA Fatty Acyl Coenzyme A,  
AEL After Egg Laying 
Akt or PKB 
AMPK Activated Protein Kinase 
AmpR Ampicillin Resistance 
ASAH1 Acid Ceramidase 
ATAC seq Assay for Transposase-Accessible Chromatin using sequencing 
ATP Adenosine Triphosphate  
Bmm Brummer 
BSA Bovine Serum Albumin 
C12- carbon chain lenght- Fatty Acyl Coenzyme A (Lauric Acid) 
C14- carbon chain lenght- Fatty Acyl Coenzyme A (Myristic Acid)  
C16- carbon chain lenght- Fatty Acyl Coenzyme A (Palmitic Acid) 
C1PP Ceramide-1-Phosphate Phosphatase,  
CerS Ceramide Synthase  
CERT Ceramide Transfer Protein 
CHARGE Consortium found an association between high levels of OCSFA 
ChIP Chromatin Immunoprecipitation 
coIP coimmunoprecipitation  
cpt1 Carnitine palmitoyltransferase  
D Aspartic Acid 
d days 
DEGS Dihydroceramide desaturase  
Df31 Decondensation factor 31  
DHR96 Drosophila Hormone Receptor 96 
DILP Drosophila Insulin Like Peptide 
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E Glutamic Acid 
Elovl4 Elongase Protein 4 
ER Endoplasmic Reticulum 
FA Fatty acids 
FAIRE seq Formaldehyde-Assisted Isolation of Regulatory Elements sequencing 
FAS Fatty Acid Synthase 
FBS Fetal Bovine Serum 
FFA Free Fatty Acids 
Flp Flippase  
FRT Flippase Recognition Target  
gDNA genomic DNA 
GFP Green Fluorescence Protein  
GO Gene Onthology 
h hours  
H Hystidine 
H3 Histone Protein  
HA Hemmaglutinin tag 
HAT Acetylase Transferases 
HDAC Histone Deacetylases  
HNF4 Hepatocyte Nuclear Factor 
Hox Hox-Domain, Homeodomain 
ILS Insulin Signaling Pathway 
INM Inner Nuclear Membrane  
InR Insulin Receptor 
IP Immunoprecipitation 
K Lysine 
KD Knock Down 
KDSR 3-keto-dehydrosphinganine reductase  
KI Knock In 
KO Knock Out 
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L1 First Instar Larva Stage 
L2 Second Instar Larva Stage 
L3 Third Instar Larva Stage 
LAG1 Longevity Assurance Gene 
LD Lipid droplet 
Lip3 Lipase 3  
LCR Low Complexity Regions 
M Methionine 
MAG Monoacylglycerols  
MAGIC Meta-Analyses of Glucose and Insulin-related traits Consortium  
MCFA Medium Chain Fatty acids  
MFI Relative mean fluorescence intensities  
NADPH Nicotinamide Adenine Dinucleotide Phosphate 
NE Nuclear Envelope 
NEFA Non-esterified fatty acids 
neGFP nuclear GFP 
NHR nuclear hormone receptor 
NLS Nuclear Localization Site 
NPC Nuclear Pore Complexes 
OCSFA Odd-Numbered Chain Saturated Fatty Acids  
ONM Outer Nuclear Membrane 
P Proline  
PBD Peroxisomal Biogenesis Disorders  
PBS Phosphate Buffer Saline 
PBST Phosphate Buffer Saline Tween 
PCR Polymerase Chain Reaction 
PEX Peroxine  
PKB protein kinase B 
PLB Passive Lysis Buffer 
PPAR Peroxisome proliferator-activated receptors 
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PUFA Poly-unsaturated fatty acids () 
qRT-PCR quantitative Real Time Polymerase Chain Reaction 
R Arginine  
RNAi RNA interference 
RP-49 Ribosomal Protein 
S2 Drosophila Schneider cells 
SCFA Short Chain Fatty Acids 
SEM Standard Error of the Mean 
Seq sequencing 
SNP Single Nucleotide Polymorphism 
SPT Serine Palmitoyltransferase 
Spx Spliceosomal Complex Protein 
SREBP Sterol Regulatory Element Binding Protein  
sty Sprouty 
T Threonine 
TAG Triacylglycerols  
TALE Transcription Activator-Like Effectors 
TF Transcription Factor 
TLC Thin Layer Chromatography 
TLC Tram-Lag-CLN8  
TM Transmembrane  
UAS Upstream Activation Sequence 
VDRC Vienna Drosophila Resource Center  
VLCFA Very Long Chain Fatty Acids  
ZF Zinc Finger 
α-CT anti- C-Terminal antibody 
α-Hox anti-homeodomain antibody 
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